Identification and characterization of conserved regulatory elements by comparative genomics by KRISH JON MATHAVAN
IDENTIFICATION AND CHARACTERIZATION OF 
CONSERVED REGULATORY ELEMENTS  






KRISH JON MATHAVAN 
(B.Sc. (Hons.) University of New South Wales) 
 
 
A THESIS SUBMITTED FOR THE  
DEGREE OF DOCTOR OF PHILISOPHY 
 
 
INSTITUTE OF MOLECULAR AND CELL BIOLOGY 




I would like to thank firstly my supervisor Byrappa Venkatesh, especially for the patience 
and support shown to me during the writing of this thesis. 
 
I would also like to thank the past and present members of the SB and FUGE lab for the 
friendship and help with techniques and reagents, especially Tay Boon Hui, Sumanti 
Tohari, Elizabeth Yeoh and Diane Tan. 
 
I would also like to thank Jian Liang from Walter’s lab; and Guo Ke, Li Jie and Bin Qi 
from the histology lab who taught me histology and provided much expertise in helping 
me fine-tune the various techniques involved, and who went out of their way to help 
whenever possible. I would also like to thank Arun from BRC who helped to make the 
transgenic work run more smoothly for me. 
 
I would like to thank members of my supervisory committee: Walter Hunziker and Wang 
Yue for the feedback given during the development of this project. 
 
Finally I would like to thank my loved one and friends both here and in Australia, who 
have been supporting me during the whole doctorate, and who have kept me strong when 
I was disheartened and who encouraged me through the thesis. 
 iii 
TABLE OF CONTENTS 
 
Acknowledgements………………………………………………………………..ii 
Table of Contents……………………………………………………………………..…iii 
 Summary…………………………………………………………………………vii 
 List of Tables……………………………………………………………………..ix 
 List of Figures……………………………………………………………………..x 
 List of Abbreviations…………………………………………………………….xii 
Chapter 1 Introduction………………………………………………………………….1 
1.1 Functional sequences in the human genome…………………………………..2 
1.2 Cis-regulatory elements……………………………………………………….3 
1.3 Cis-regulatory elements and genetic diseases…………………………………5 
1.4 Identification of cis-regulatory elements……………………………………...7 
1.4.1 Traditional methods………………………………………...……..8 
1.4.2 High throughput methods………………………………………..10 
1.5 Using comparative genomics to identify cis-regulatory elements…………...12 
1.5.1 Comparison of closely related species……………..…………….13 
1.5.2 Extreme conservation within mammals………………………….16 
1.5.3 Comparison of distantly related vertebrates……………………..18 
1.5.4 Alignment and visualization tools for comparative genomics…..24 
1.6 Objectives of the present study………………………………………………27 
Chapter 2 Materials and methods…………………………………………………......32 
 iv 
2.1 Genomic sequence alignment and prediction of conserved noncoding 
sequences………………………………………………………………………...33 
2.2 Generation of DNA constructs for microinjection…………………………..35 
2.3 Isolation and sequencing of fugu cosmid to map the orexin locus…………..36 
2.4 Generation of transgenic mice……………………………………………….37 
2.5 Preparation of DNA for microinjection……………………………………...38 
2.6 Genotyping…………………………………………………………………...39 
2.7 In situ hybridization………………………………………………………….41 
2.7.1 Preparation of embryos and tissues for whole-mount or section in 
situ hybridization………………………………………………………...41 
2.7.2 Synthesis of RNA probes for in situ hybridization………………..43 
2.7.3 Pretreatment of embryos and sections……………………………..44 
2.7.4 Hybridization, washing and antibody addition…………………….46 
2.7.5 Visualization……………………………………………………….47 
2.7.6 Double in situ hybridization………………………………………..49 
Chapter 3 Results: Identification of CNEs in forebrain genes………………………50 
 3.1 Introduction…………………………………………………………………..51 
 3.2 Identification of human, mouse and fugu forebrain genes…………………..52 
 3.3 Prediction of CNEs…………………………………………………………..52 
 3.4 Summary……………………………………………………………………..58 
Chapter 4 Results: Regulation of Six3………………………………………………...60 
 4.1 Introduction…………………………………………………………………..61 
 4.2 Six3 loci in human, mouse and fugu; and identification of CNEs…………...62 
 v 
 4.3 Expression pattern of mouse Six3……………………………………………67 
 4.4 Functional assay of Six3 CNEs………………………………………………70 
4.4.1 Basal promoter region (includes CNE13) of mouse Six3 is sufficient 
to recapitulate most aspects of expression in the forebrain and eye during 
early and late stages of development…….………………………………70 
4.4.2 Expression patterns directed by CNE1, CNE2/3/4 and CNE5/6/7...74 
4.4.3 Expression patterns directed by CNE8/9 and CNE12……..………76 
4.4.4 CNE10/11 silences the mouse Six3 promoter at all developmental 
stages….……………..…………………………………………………...81 
4.4.5 Expression pattern directed by CNE14……...……………………..81 
4.4.6 Summary of the regulatory potential of mouse Six3 CNEs………..82 
 4.5 Discussion……………………………………………………………………83 
  4.5.1 Comparison of results from Six3 regulation in medaka ……………86 
Chapter 5 Results: Regulation of Foxb1………………………………………………90 
 5.1 Introduction…………………………………………………………………..91 
 5.2 Comparison of Foxb1 loci in human, mouse and fugu………………………92 
 5.3 Expression pattern of mouse Foxb1………………………………………….96 
 5.4 Functional assay of Foxb1 CNEs…………………………………………….99 
5.4.1 Basal promoter region (includes CNE3) of mouse Foxb1 is sufficient 
to recapitulate most aspects of endogenous expression during early and 
late stages of development……………………………………………….99 
5.4.2 Expression patterns directed by CNEs 1, 2, 4 and 5……………...102 
5.4.3 Summary of the regulatory potential of mouse Foxb1 CNEs…….107 
 vi 
5.4.4 Conservation of regulation of Foxb1 between fugu and mouse….108 
 5.5 Discussion…………………………………………………………………..111 
Chapter 6 Results: Regulation of Orexin ……………………………………...…….118 
 6.1 Introduction…………………………………………………………………119 
 6.2 Comparison of ORX loci in human, mouse and fugu………………………121 
 6.3 Expression of fugu ORX in mouse…………………………………………123 
6.4 Comparative analyses and validation of ORX regulatory elements common in 
human, mouse and fugu………………………………………………………...127 
6.5 Discussion…………………………………………………………………..133 
Chapter 7 General Discussion.......................................................................................138 
 7.1 Summary……………………………………………………………………139 
 7.2 High-success rate in identifying functional cis-regulatory elements……….140 
 7.3 Cooperativity and redundancy in cis-regulatory elements………………….142 
7.4 Conserved function of cis-regulatory elements in mammals and fish without 











Comparative genomics is a powerful approach for identifying cis-regulatory elements in 
the human genome. Noncoding sequences that exhibit high level of conservation between 
genomes are likely to be under purifying selection and represent functional elements such 
as cis-regulatory elements. The pufferfish (fugu) is a particularly attractive model for 
discovering cis-regulatory elements in the human genome because of its compact intronic 
and intergenic regions, and its maximal evolutionary distance (~420 million years) from 
human. The aim of this study is to use fugu to predict conserved noncoding elements 
(CNEs) in genes expressing in the human forebrain, and to characterize selected CNEs in 
transgenic mice to identify cis-regulatory elements that direct tissue-specific expression 
in developing embryos. To this end, genomic sequences for 50 human genes that express 
in the forebrain were aligned with their orthologous sequences in mouse and fugu using a 
global algorithm program (MLAGAN) and CNEs were predicted using the criteria of at 
least 60% identity over 50 bp. Altogether 206 CNEs (total length ~30 kb) associated with 
29 genes were identified. CNEs associated with two transcription factor genes, Six3 and 
Foxb1, were assayed in transgenic mice using a lacZ reporter gene. All the CNEs assayed 
were found to function as cis-regulatory elements by either enhancing or suppressing 
expression of the reporter gene in a tissue- and developmental-stage specific manner. 
Interestingly, the highly conserved basal promoter regions of Six3 and Foxb1 genes were 
found to contain regulatory elements required for expression in almost all the domains in 
early and late stages of development, while the CNEs dispersed in the intergenic regions 
were found to ‘fine-tune’ the expression driven by the basal promoter by enhancing or 
silencing expression in particular domains. Many CNEs were found to have overlapping 
 viii 
expression patterns reflecting the redundancy built into the regulatory code for ensuring 
the correct spatial and temporal expression patterns of genes. These results demonstrate 
that comparative genomics using fugu is a useful approach for identifying evolutionarily 
conserved cis-regulatory elements in the human genome.  
 
I also analyzed the regulatory region of orexin (ORX) gene which did not contain CNEs, 
in order to understand the molecular basis of cell-specific expression of such genes. 
Despite the absence of CNEs, the fugu ORX regulatory region was able to direct neuron-
specific expression in the hypothalamus of transgenic mice. Close inspection of 
sequences revealed cis-regulatory elements with sequence identities below the threshold 
level of CNEs. These vertebrate genes appear to be associated with two types of 
enhancers: one that is highly constrained in structure and organization and detected by a 
high level of sequence conservation in distant vertebrates; and another one that is weakly 
constrained and flexible in its organization and requires comparison with closely and 
distantly related species and identification by conservation at the level of transcription 
factor-binding sites. Thus, alternative strategies are required for the identification of all 
the cis-regulatory elements in the human genome.  
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         Chapter 1 
 





1.1 Functional sequences in the human genome 
The Human Genome Project is the largest project ever attempted in biological sciences. 
Its main objectives are to determine the complete sequence of the human genome, and to 
identify and characterize all functional elements which would lead to a more complete 
understanding of the structure, function and evolutionary history of the human genome. 
The first objective was largely accomplished in 2001 when two “draft” sequences were 
generated (Lander et al., 2001; Venter et al., 2001). Most of the gaps in these draft 
sequences have since been filled-up and now the human genome sequence is essentially 
complete (International Human Genome Sequencing Consortium, 2004). However, 
although about 21,000 protein coding genes comprising about 1.5% of the human 
genome have been predicted, we are still far from identifying all functional elements. 
Since we have a good understanding of the genetic code and structure of protein coding 
genes, on hindsight, predicting protein-coding sequences was the easiest part of the 
annotation. Identifying and characterizing the “other” functional elements in the human 
genome which do not have a well-defined structure like the protein-coding genes, has 
become a major challenge in this post-human genome sequencing era.  
 
How much of the 3000-Mb human genome sequence is functional? This is a highly 
debated issue with estimates ranging from 3% to 70% depending on the method used for 
identifying functional elements (Pheasant and Mattick, 2007; Waterston et al., 2002). A 
typical method for identifying functional sequences is by comparing the human genome 
sequence with related genomes and estimating the portion of the genome that is evolving 
more slowly than the neutrally evolving sequences. The slowly evolving sequences that 
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are under selective constraint are likely to be functional elements in these genomes. A 
systematic comparison of the whole genome sequences of the human and mouse genomes 
has indicated that about 5% of these genomes are under selective constraint since they 
diverged from a common ancestor. This implies that at least 5% of the human and mouse 
genomes comprise functional sequences (Waterston et al., 2002). Since the protein-
coding sequences account for 1.5% of these genomes, this analysis indicates that 
noncoding functional elements are three-fold higher than protein-coding sequences, and 
underscores the challenge in identifying and characterizing these functional elements. 
The non-coding functional sequences in the human genome include RNA genes such as 
transfer RNA (tRNA), ribosomal RNA (rRNA), and small RNAs like small interfering 
RNA (siRNA) and micro RNA (miRNA); transcriptional regulatory elements; splicing 
regulatory elements; sequences conferring structural chromatin features; and sequences 
playing a role in chromosomal replication and recombination. The main objective of my 
work is to identify and characterize transcriptional regulatory elements (referred to as 
“cis-regulatory elements” or “enhancers” in this thesis) in the human genome.  
 
1.2 Cis-regulatory elements  
Cis-regulatory elements are DNA sequences that mediate spatial and temporal expression 
patterns of genes. Transcription factors bind to cis-regulatory elements and activate or 
repress transcription of target genes associated with the cis-regulatory element in a cell-
type or tissue-specific manner at specific developmental stages. Cis-regulatory elements 
comprise binding sites for transcription factors that are often organized into clusters 
called cis-regulatory modules (CRMs) or enhancers. The CRMs typically span a few 
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hundred nucleotides, and can contain dozens of binding sites for ~3-10 transcription 
factors that activate or repress gene transcription (Chen and Rajewsky, 2007). Complex 
gene expression patterns frequently evolve from an orchestrated activity of several 
different cis-regulatory modules with distinct spatiotemporal activity patterns. For 
instance, in the Drosophila embryos the even-skipped (eve) gene, a pair-rule gene, is 
transcribed in alternate embryonic parasegments to generate a zebra pattern of seven 
stripes. The transcriptional state of this gene - either ON or OFF depending on which 
parasegment - is under the control of a series of CRMs, with about one module 
responsible for expression in each stripe (Sackerson et al., 1999).  
 
Cis-regulatory elements also confer regulatory control in the timing of gene expression. 
For example, there is emerging evidence that the precise temporal expression of Hox 
genes is crucial for the establishment of regional identities. Deletion of the Hoxd11 
enhancer in mice delays expression of both Hoxd10 and Hoxd11 during somitogenesis, 
but at a later stage, normal expression of both genes is restored (Zakany et al., 1997). 
However this regulatory deletion could not prevent the occurrence of defects in 
patterning and specification of the vertebral column, although these were of less severity 
than the complete Hoxd11 gene knockout (Zakany et al., 1997). Another similar study 
showed that the deletion of an early enhancer of Hoxc8 resulted in a significant delay in 
the temporal expression but did not eliminate the expression of the Hoxc8 protein. It 
delayed the attainment of control levels of expression and anterior and posterior 
boundaries of expression on the anterior-posterior axis and this temporal delay in Hoxc8 
expression was sufficient to produce phenocopies of many of the axial skeletal defects 
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associated with the complete absence of the Hoxc8 gene product (Juan and Ruddle, 
2003).  
 
Cis-regulatory elements can reside close to the basal promoter, in introns, or in the 5’ and 
3’-flanking sequences of their target genes. In some vertebrate genes, cis-regulatory 
elements termed ‘long-range enhancers’, are located at several hundred kilobases away 
from the target gene (Bagheri-Fam et al., 2006; de la Calle-Mustienes et al., 2005; 
Kimura-Yoshida et al., 2004; Nobrega et al., 2003). In some instances, the long-range 
enhancers are embedded in the introns of the neighbouring genes. For example the limb 
enhancer of Sonic Hedgehog (SHH) gene has been found in the 5th intron of the 
neighbouring limb region 1 homolog (LMBR1) gene that is 1Mb upstream (Lettice et al., 
2003); and the retina enhancer of the paired box gene 6 (Pax6) gene was found located in 
the intron of the neighbouring elongation protein 4 homolog (ELP4) gene that is located 
200 kb downstream (Kleinjan et al., 2001). Thus, cis-regulatory elements can be 
potentially located within the introns or anywhere in the flanking regions of their target 
genes. 
 
1.3 Cis-regulatory elements and genetic diseases 
Cis-regulatory elements have emerged as primary candidates that are likely to harbour 
mutations contributing to human disease phenotypes. Although disease-associated 
genetic changes commonly affect gene coding regions, some may exert their effect 
through abnormal gene expression that results from mutations in cis-regulatory elements 
that affect their interaction with the promoter and/or disrupt the chromatin structure of the 
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locus (Kleinjan and van Heyningen, 2005). The most obvious cases of transcriptional 
misregulation as the cause of genetic disease are associated with visible chromosomal 
rearrangements. For example, aniridia (absence of iris) and related eye anomalies are 
caused mainly by haploinsufficiency of the paired box / homeodomain gene Pax6 at 
human chromosome 11p13 (van Heyningen and Williamson, 2002). A number of aniridia 
human subjects have been described with no identifiable mutation in the transcription 
unit. Instead chromosomal rearrangements that disrupt the region downstream of the 
Pax6 transcription unit have been implicated. Detailed mapping of the breakpoints placed 
them about 125 kb beyond the final exon. Analysis of the region beyond this breakpoint 
revealed the presence of a downstream regulatory region (DRR) located about 200 kb 
away and within the intron of the adjacent ubiquitously expressed ELP4 gene (Kleinjan et 
al., 2001). Deletion of this DRR showed that it is absolutely essential for expression of 
Pax6 in the retina and iris, even in the presence of more proximal known retinal 
enhancers, and explains why the aniridia phenotype in ‘position effect’ patients is 
indistinguishable from aniridia in patients carrying coding region mutations in Pax6 
(Kleinjan et al., 2006). 
 
On the other hand, the phenotype caused by a regulatory mutation can be very different 
from that caused by a coding region mutation, because such mutations may only be 
affecting a subset of expressing tissues. The involvement of SHH in preaxial polydactyl 
(the formation of additional anterior digits in the vertebrate limb) fits such a scenario, 
because while SHH functions in brain and neural development, it also plays a key role in 
defining the limb anterior-posterior axis (Kleinjan and van Heyningen, 2005). Normally 
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SHH is transiently expressed in the posterior part of the mouse limb and sets up a 
morphogen gradient from this zone of polarizing activity to instruct cells with respect to 
their antero-posterior fates and to specify digit identities. The limb-specific long-distance 
enhancer of SHH is located at the extreme distance of 1 Mb from the gene it regulates, 
residing in the intron of a neighbouring gene Lmbr1, and genetic lesions affecting this 
element is responsible for the ectopic expression of SHH in the limb bud, resulting in 
preaxial polydactyl in humans (Lettice et al., 2002). These instances of genetic diseases 
highlight the need for a comprehensive cataloging and characterization of cis-regulatory 
elements in the human genome, which should facilitate the identification and validation 
of functionally significant variants and pathological mutations in the regulatory regions 
of the genome. 
 
1.4 Identification of cis-regulatory elements  
Given that cis-regulatory elements comprise clusters of transcription factor binding sites 
and such sites are typically short (6 to 10 bp long) and allow degeneracy in their 
sequences, identifying functional cis-regulatory elements in the vast non-coding regions 
of the human genome is a non-trivial exercise. Although individual transcription factor 
binding sites can be predicted in silico based on similarity to experimentally validated 
binding sites, such predictions are likely to contain a large number of false positives. 





1.4.1 Traditional methods 
Traditional methods of identifying cis-regulatory elements can be categorized into 
biochemical and genetic methods. Biochemical methods typically make use of the way 
DNA is packaged in the cell. Histone proteins act like molecular spools that coil the 
strands of DNA into bead-like units called nucleosomes, which help to organize the 
higher levels of chromatin structure. Genes in these tightly condensed regions are not as 
accessible for gene expression as compared to genes that have been unwound from their 
nucleosome structure. As such, DNA that is ‘unpacked’ would often be hypersensitive to 
endonucleases such as DNase I, and DNase I hypersensitive sites are good indicators of 
the presence of enhancers. To identify DNase I hypersensitive sites, nuclei are prepared 
from cells or a tissue and incubated with various concentrations of DNase I, and the DNA 
is then extracted and digested with a restriction enzyme to make a defined end from 
which the hypersensitive sites can be located. Early observations suggest that 
hypersensitivity is associated with the removal of nucleosomes but more recent analyses 
detect the presence of histones in modified form such as acetylation of histone H3 on 
lysines 9 and 14 that reduce the affinity of the DNA for the nucleosome (Bernstein et al., 
2005). This in turn would facilitate the interaction of DNA with trans-acting factors, and 
this property is made use of in DNase I footprinting where bound transcription factors 
will tend to protect the ‘unpacked’ enhancer DNA from DNase I and produce a 
characteristic ‘footprint’ when fractionated on a gel. However this method requires prior 
knowledge of the transcription factors that bind the enhancer. Gel shift assays, known as 
electrophoretic mobility shift assays (EMSA) can also be used to show that a known 
transcription factor binds to a site in the cis-regulatory element. The labeled DNA in the 
 9 
form of an oligo is incubated with nuclear extract containing the transcription factor, and 
the mix is fractionated on an acrylamide gel. The transcription factor will retard the DNA 
to which it is bound as compared to the unbound DNA, and the ‘shifted’ band can be 
recognized easily on the gel. This method also requires prior knowledge of the 
transcription factor, nuclear extract from the cell types in which the gene is expressed 
(could be a problem if genes express in a small population of cells) and may involve a 
large number of oligos if the candidate cis-regulatory regions span a large distance. 
 
Candidate cis-regulatory elements can be validated for their transcription activating 
potential using genetic assays that provide the appropriate array of transcription factors 
and conditions in which they can bind. The best assay system is an in vivo whole 
organism but tissue explants may be used when more rapid alternatives are needed. 
Assays in cell lines offer an attractive rapid system, if appropriate cell lines that show 
specific expression of genes of interest are available. Whole animal in vivo assay, 
however, provides the best means of assessing functional elements in a biologically 
relevant and tissue-specific context, and is the method of choice if the gene of interest is 
developmentally regulated. The region of the candidate cis-regulatory element is cloned 
upstream of a reporter gene and introduced into the system, and the expression of the 
reporter mRNA or protein is measured in specific cells or tissues and in response to 
regulatory signals. To locate the exact position of the cis-regulatory element, progressive 
deletions are carried out until the minimal region required for activity is identified. These 
experiments, however, are tedious, time consuming and expensive particularly if the 
candidate cis-regulatory regions are large as in the case of human genes. 
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1.4.2 High-throughput methods 
The human genome sequencing era heralded the development of high-throughput 
methods to discover functional elements on a genome-wide scale. These methods can be 
classified into biochemical methods and computational methods. One recently developed 
biochemical method involves the use of DNase I hypersensitivity to measure the 
appearance and disappearance of functional sites on a genome-wide scale by comparing 
between cells of different tissues or comparing within the same type of cell in response to 
changes in the cellular environment. This method has taken form in two recently 
developed techniques known as quantitative chromatin profiling (Dorschner et al., 2004) 
and massively parallel signature sequencing (Crawford et al., 2006). At present these 
high throughput methods are limited in scope by the number of cell lines or tissue types 
available, and can produce many false positives caused by non-specific digestion of 
DNase at non-hypersensitive sites (Crawford et al., 2004).  
 
Another increasingly popular method is the chromatin immunoprecipitation (ChIP) assay, 
which is a modification of the ‘pull down’ assays in which target proteins are precipitated 
from solution using an antibody coupled to a retrievable tag. ChIP assays capture in vivo 
protein-DNA interactions by cross-linking proteins to their DNA recognition sites using 
formaldehyde, fragmenting the protein-bound DNA, probing this DNA with a 
transcription factor-specific antibody and then reversing the cross-linking to release the 
bound DNA for subsequent detection by PCR amplification. Caveats to using the ChIP 
assay include recovering indirect interactions caused by protein-protein contact rather 
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than protein-DNA interactions and the inability to detect precise contacts of binding 
within the 500 bp region (average fragment size after shearing the chromatin) of the DNA 
probe (Elnitski et al., 2006). High-throughput variations of the ChIP technique use 
ligation-mediated PCR to amplify the pool of DNA sequences as uniformly as possible, 
generating many copies of all genomic binding sites for a given protein. The assortment 
of enhancers containing these binding sites recovered in a ChIP assay can then be 
visualized by hybridization to a microarray of genomic sequences (Elnitski et al., 2006). 
This approach called ChIP-chip has been used recently to interrogate protein-DNA 
interactions in intact cells and in a genome-wide fashion (Kim et al., 2005). 
Unfortunately ChIP-chip results are dependent on the availability of suitable microarrays 
with high coverage and resolution, and on the affinity and specificity of the antibodies 
used to recognize and bind the native protein of interest (Hudson and Snyder, 2006). In 
addition, there is the possibility of background DNA being ‘pulled down’ by nonspecific 
interactions of protein and DNA, leading to false positives. Optimization of ChIP-chip 
has helped somewhat to decrease the false positive rate by paying attention to several key 
basics like immunoprecipitation handling, optimization of array binding conditions and 
the use of appropriate controls (Wu et al., 2006). Arrays used should contain a 
representation of the entire genome whenever possible so as to facilitate comparison 
between different loci represented on the array and to identify the ‘best’ candidate 
enhancers (Hanlon and Lieb, 2004). 
 
Computational methods of identifying enhancers generally rely on their modular nature 
that comprises multiple transcription factor binding sites often in close proximity to each 
 12 
other. This clustering of sites for relevant transcription factors is considered a reliable 
indicator of regulatory function and has been used for the computational prediction of 
enhancers in coregulated genes that would share the same cluster of binding sites. Most 
of this kind of work has been carried out in Drosophila (Berman et al., 2004; Markstein et 
al., 2004). However these computational methods rely on previous knowledge of the 
transcription factor binding sites and composition of several experimentally characterized 
cis-regulatory elements in order to construct the predictive models, but the number of 
such datasets are very limited in vertebrates, which poses an obstacle in the training and 
testing of these methods. Recently a landmark study was carried out that identified more 
than 118,000 cis-regulatory modules in the human genome using existing transcription 
factor binding site information, but with no prior knowledge about coregulated genes or 
combinations of factors that are likely to co-occur in a module (Blanchette et al., 2006). 
Although a subset of these modules was shown to be bound in vivo by transcription 
factors using ChIP-chip, the predictions nevertheless contained a significant number of 
false positives (Blanchette et al., 2006). On the other hand, computational approaches 
have been more successful in identifying cis-regulatory elements when used in sequence 
comparisons between related vertebrate species, and this is elaborated in the next section. 
 
1.5. Using comparative genomics to identify cis-regulatory elements 
Soon after the completion of the human genome sequence, genomes of several 
vertebrates were sequenced starting with the genome of the pufferfish, Fugu rubripes, in 
August 2002 (Aparicio et al., 2002) and mouse in December 2002 (Waterston et al., 
2002). Since then the genomes of several vertebrates have been completed (Miller et al., 
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2007). The availability of whole genome sequences of these vertebrates has provided an 
unprecedented opportunity to identify functional elements in the human genome using a 
comparative genomics approach. This approach relies on the principle that functionally 
relevant sequences are under purifying selection whereas non-functional regions are 
subject to neutral evolution and become divergent between species whereby functional 
sequences tend to stand out as more conserved than non-functional sequences. This 
approach is also known as “phylogenetic footprinting” because the constrained sequences 
leave behind a ‘footprint’ in the alignment of DNA sequences from multiple species. 
Phylogenetic footprinting, particularly in the non-coding region, reduces the sequence 
search space in a biologically meaningful way. The comparison of genomes for 
identifying functional noncoding elements in the human genome can be based on 
vertebrate genomes that are phylogenetically closely related to human (e.g., other 
mammals) or distantly related to human (e.g., teleost fishes). The comparisons at the 
extreme ends of the vertebrate phylogenetic tree have their own advantages and 
disadvantages. 
 
1.5.1 Comparison of closely-related species 
A pioneering study that used close-species comparison for identifying functional 
noncoding sequences in the human genome is that by Loots et al. (2000). In this study, 
about 1 Mb of human 5q31 region spanning the interleukin-4 (IL-4), interleukin-13 (IL-
13), and interleukin-5 (IL-5) gene clusters was compared with its orthologous region in 
the mouse and 90 noncoding sequences that exhibited equal to or greater than 70% 
identity over 100 bp or longer were identified. Functional characterization of the largest 
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of these noncoding sequences (401 bp long residing in the intergenic region between IL-4 
and IL-13) in transgenic mice revealed that it functions as a coordinate regulator of three 
IL genes (IL-4, IL-13 and IL-5) spread across 120 kb (Loots et al., 2000). Because the 
functional assay demonstrated that the noncoding element is a functional element 
(transcriptional enhancer), the threshold values used in this study for defining conserved 
noncoding sequences (≥70% identify across ≥100 bp) has since been routinely used for 
identifying conserved putative functional noncoding sequences, such as in a 
comprehensive comparative analysis of human chromosome 21 with syntenic regions of 
the mouse genome (Dermitzakis et al., 2002). Although highly conserved noncoding 
sequences have proven to be good indicators of regulatory elements, not all human-
mouse alignments identified using a single conservation criterion necessarily indicate 
functional sequences, owing to the substantial variation in the rate of evolution from 
region to region in human and mouse genomes (Hardison et al., 2003; Waterston et al., 
2002). Furthermore, because of the relatively short divergence period (70 million years) 
between human and mouse lineages, the high level of similarities in some regions could 
be due to a lack of adequate time for divergence of non-essential DNA rather than due to 
purifying selection. Thus, although human-mouse (or other phylogenetically closely 
related species) comparison is effective in identifying a large number of conserved 
noncoding sequences, such comparisons suffer from low specificity and contain many 
false positive predictions.  
 
One effective way to increase the specificity in close species comparisons is to increase 
the number of species compared. The rationale of multiple genome alignment is to 
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maximize combined branch length of the phylogenetic tree to ensure enough evolutionary 
time has elapsed so that non-functional regions have sufficiently diverged, resulting in 
higher specificity in detecting functional conserved sequences (Margulies et al., 2003). 
Therefore increasing the number of species used in genome comparisons makes it 
progressively less probable that sequences are conserved by chance, and helps in the 
identification of truly functional conserved sequences to be prioritized for experimental 
analysis. The recent examples that utilized multiple alignment of mammalian genome 
sequences include the discovery of regulatory motifs in human promoters and 3’ UTRs 
by comparing the human genome with the mouse, rat and dog genomes (Xie et al., 2005), 
and the comprehensive identification of conserved non-coding sequences that were 
missed in human-mouse comparisons alone by aligning up to 12 mammalian genomes, in 
the analysis of a 1.8 Mb interval on human chromosome 7  (Margulies et al., 2005; 
Thomas et al., 2003).  
 
Comparisons of much more closely related species such as human and non-human 
primates are generally dismissed as uninformative owing to their inherent sequence 
similarity caused by the relatively short period since they diverged from their last 
common ancestor in the primate branch, which is for example about 25 million years for 
humans and old world monkeys (Boffelli et al., 2003). On the other hand, human-primate 
comparisons have been used more widely to detect sequence differences that reflect 
positive selection in protein-coding (Enard et al., 2002) and noncoding regions (Pollard et 
al., 2006) that would give rise to rapid evolution in the human lineage. The closely 
related species do indeed contain biological insights that are not available from 
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comparisons between species that are more evolutionarily divergent, for example 
primate-specific functional elements that arose in the primate lineage, which are 
responsible for phenotypes unique to primates. To overcome the lack of sequence 
variation observed between human and their primate relatives, a different approach called 
“Phylogenetic shadowing” involving comparisons of numerous closely related primate 
species has been developed (Boffelli et al., 2003). This approach takes into account the 
phylogenetic relationship of the set of species analyzed and identifies regions that 
accumulate variation at a slower rate in all the species (Boffelli et al., 2003). This method 
is uniquely suited to identifying primate-specific functional elements and has only been 
used in the context of particular loci of interest since there are currently not enough 
completed primate genomes to facilitate genome-wide comparisons. More recently, 
phylogenetic shadowing has been used to uncover conserved regulatory elements in a 
comparison of as few as 6 non-human primates and notably, the mouse orthologs of these 
elements retained regulatory activity despite the lack of significance sequence 
conservation (Wang et al., 2007). Therefore, comparisons between primate genomes can 
be used to detect both primate-specific and ancestral mammalian regulatory elements.  
 
1.5.2 Extreme conservation within mammals 
In an attempt to identify a core set of highly conserved functional elements in the human 
genome, extreme conservation has been used as an indicator of function. The extremely 
conserved elements, known as “ultraconserved elements” (UCEs), are defined as 
sequences that are 200 bp or longer and completely conserved (100% identity without 
insertions or deletions) in the human, mouse and rat genomes (Bejerano et al., 2004). 
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Using these criteria Bejerano et al. (2004) identified 481 UCEs. Of these, 256 are 
nonexonic UCEs located in the noncoding regions of the genome. Unlike the exonic 
UCEs which tend to be associated with RNA genes, nonexonic UCEs tend to cluster 
around transcription factor-encoding genes and genes involved in development. It was 
therefore proposed that the nonexonic UCEs function as transcriptional enhancers 
directing the precise spatial and temporal expression patterns of the developmental 
regulatory genes (Bejerano et al., 2004). Consistent with this hypothesis, experimentally 
validated enhancers of some transcription factor genes (e.g., DACH1, Iroquois) overlap 
nonexonic UCEs (de la Calle-Mustienes et al., 2005; Nobrega et al., 2003; Poulin et al., 
2005). Furthermore, functional assay of 84 nonexonic UCEs in transgenic mice have 
confirmed that 51 of them are positive enhancers that directed tissue-specific reporter 
gene expression at embryonic day 11.5 (e11.5) (Pennacchio et al., 2006). This revealed a 
high propensity (~60%) of ultraconserved human noncoding sequences to behave as cis-
regulatory elements in vivo. Interestingly, knockout of four nonexonic UCEs that had 
shown transcriptional enhancer activity in vivo, had no measurable phenotypic 
consequences on the knockout mice, implying that these UCEs are functionally redundant 
in spite of their remarkable conservation (Ahituv et al., 2007). Moreover, a large-scale 
transgenic mouse assay comparing the enhancer activity of almost all 256 nonexonic 
UCEs, with a similar number of extremely constrained CNEs lacking ultraconservation 
but having high human-rodent P-values (Prabhakar et al., 2006) showed that 
developmental enhancers were equally prevalent (about 50%) in both types of conserved 
elements (Visel et al., 2008). These results indicate that UCEs are only a subset of 
extremely constrained human-rodent noncoding elements that posses enhancer function. 
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As such, although non-exonic UCEs provide a high likelihood of identifying enhancers, 
they represent a relatively small subset of functionally conserved sequences that are 
under similar constraint in the human genome, and that many functional elements will 
still be missed if ultraconservation is used as the sole criteria for screening noncoding 
regions (Visel et al., 2007). 
 
1.5.3 Comparison of distantly-related vertebrates 
Comparison of human genome with phylogenetically distant vertebrates such as teleost 
fishes that diverged from the mammalian lineage about 420 million years ago is an 
effective method for identifying conserved functional noncoding sequences because all 
the neutrally evolving sequences would have diverged beyond recognition during this 
long evolutionary period and those that have not diverged are likely to be under purifying 
selection. Such deep comparison essentially offers low sensitivity but high specificity 
whereby most of the conserved sequences identified are likely to be functional elements. 
The proof of principle for this approach was first demonstrated by Aparicio et al. (1995) 
who used mouse and fugu comparison to identify developmental enhancers in the Hoxb-4 
locus. Of the three blocks of conserved noncoding sequences (designated CR1, CR2 and 
CR3) identified at this locus, one element (CR1) was found to be responsible for 
directing expression in the mesoderm and ectoderm while CR3 was capable of directing 
expression to neural tube in  10.5 day old mouse embryos (Aparicio et al., 1995). 
Subsequently this approach was used to identify and validate cis-regulatory elements in 
several loci in the human genome, such as Sox9 (Bagheri-Fam et al., 2001); Pax6 (Griffin 
et al., 2002); Pax9 and Nkx2-9 (Santagati et al., 2003); and the Dlx bigene clusters 
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(Ghanem et al., 2003). Human-fugu comparison has been found to be particularly useful 
in prioritizing conserved noncoding sequences identified in the large intergenic regions of 
gene deserts. For example, the human gene DACH is expressed in numerous tissues and 
involved in the development of brain, limb and sensory organs, and is located in one of 
the gene deserts. It is flanked by 870 kb 5’ intergenic and 1.3 Mb 3’ intergenic regions. 
Comparison of the human and mouse DACH loci identified more than 1000 conserved 
noncoding elements (each longer than 100 bp long and >70% identical), but this number 
was reduced to 32 by comparison with several distant vertebrates including fugu. In vivo 
mouse transgenic assay of nine of these elements showed that seven of them functioned 
as transcriptional enhancers recapitulating several aspects of the complex endogenous 
DACH expression in 12.5 and 13.5 days post coitum mouse embryos (Nobrega et al., 
2003). This demonstrates that distant vertebrates such as fugu help in prioritizing 
conserved elements for functional assays. 
 
Besides fugu, other teleost fishes such as zebrafish have also been used in mammalian-
fish comparisons of homologous gene loci to identify cis-regulatory elements. For 
example, two blocks of conserved noncoding sequences were identified between the 
zebrafish Dlx5/Dlx6 genes and their mammalian homologs with over 80% identity across 
>600 bp of sequence, and their functionality was demonstrated in transgenic mice 
(Zerucha et al., 2000). A sequence comparison of the human and zebrafish SHH loci 
detected short stretches of conservation in the intronic regions and the upstream promoter 
(Muller et al., 1999). When the conserved intronic fragment was introduced into 
transgenic animals, the zebrafish homolog directed floor plate and notochord expression 
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in both developing mouse and zebrafish embryos while the mouse homolog was 
exclusively floor-plate-specific, suggesting that some of the cis-regulatory mechanisms 
involved in regulating SHH expression are conserved between zebrafish and mice (Jeong 
and Epstein, 2003; Muller et al., 1999). However, unlike the fugu genome with its 
tendency toward a compact genome, the zebrafish genome has retained a higher number 
of duplicated genes that were generated as a result of a ‘fish-specific’ whole genome 
duplication event (Christoffels et al., 2004; Taylor et al., 2003), and it is necessary in 
most instances to compare the mammalian gene locus with its two zebrafish orthologs. 
This can be complicated if one of the duplicate genes has diverged considerably and 
acquired novel expression domains. 
 
Whole genome comparisons of human and teleost fishes have also been effective in 
identifying a large number of putative cis-regulatory elements in the two genomes. 
Alignment of human and fugu genomes using the local alignment algorithm 
MegaBLAST identified 1,373 highly conserved noncoding elements (>100 bp long and 
>70% identical). These elements are distributed in a non-random manner in the genome, 
with a large number of them found in clusters predominantly in the vicinity of genes 
involved in transcription and development (Woolfe et al., 2005). Functional assay of 25 
of these conserved elements in transgenic zebrafish indicated that 23 of them exhibit 
enhancer activity in one or more tissues (Woolfe et al., 2005). Taken together, these data 
indicate that a majority of the elements conserved in the human and fugu genomes 
function as cis-regulatory elements of transcription factor-encoding and developmental 
genes. A similar genome-wide comparison of human and fugu using a different approach 
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based on quantifying the rate of decline of noncoding sequence conservation with 
increasing evolutionary distance by employing probability scores instead of a 
conservation window (Prabhakar et al., 2006), identified about 5,700 human-fugu 
conserved noncoding sequences. Functional assay of 137 of these elements in transgenic 
mouse showed that 57 of them direct tissue-specific expression in 11.5 day old embryos 
(Pennacchio et al., 2006). Genome-wide comparisons of human and zebrafish using the 
ECR browser (Ovcharenko et al., 2004) that utilized the local alignment BLASTZ were 
also able to identify a large number of putative regulatory elements. Using a conservation 
criteria of more than 70% identity and over 80 bp in length a total of about 4,800 
conserved noncoding sequences were identified (Shin et al., 2005). 16 of these conserved 
elements were randomly chosen for experimental validation, and 11 were found to be 
positive for transcriptional upregulation using a dual luciferase system in transgenic 
zebrafish. A dual reporter system was used to allow for normalization of reporter activity 
due to the mosaic expression known to occur in zebrafish transient transgenesis. These 
elements were also found to be enriched for genes involved in development and 
transcription factor activity, consistent with the findings of human-fugu whole-genome 
comparisons (Shin et al., 2005). Yet a recent study also showed that conserved regulatory 
modules might be found in genes other than transcription factor and developmental 
regulators more frequently, if one included the possibility that regulatory modules were 
rearranged or shuffled within the loci (Sanges et al., 2006). This study first identified 
conserved noncoding sequences in at least three mammalian genomes (human, mouse 
and dog or rat) of at least 100 bp in length having a percentage identity of at least 70%. 
These conserved elements were then used to screen the fugu, zebrafish and Tetraodon 
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genomes to identify shorter conserved fragments of at least 40 bp in length and 60% 
identity to the mouse element using a method called CHAOS (Brudno et al., 2003a) that 
allowed for the identification of short 10 bp regions that are reversed or moved in the fish 
locus with respect to the corresponding mammalian locus. Approximately 21,500 
conserved elements were found, with 72% of the elements shuffled. Of the total of 27 of 
these elements selected for functional assay, 22 were able to direct tissue-specific 
expression of a reporter gene in transgenic zebrafish embryos (Sanges et al., 2006). While 
this unique approach has been more sensitive in identifying conserved noncoding 
sequences in fish, the use of short word sizes in the algorithm to aid in fish-mammalian 
alignments is likely to make it more difficult to distinguish between biological features 
preserved through evolution and neutrally evolving short fragments in the genome. 
 
Cartilaginous fishes are a more ancient group of vertebrates than teleost fishes. They 
diverged from the common ancestor of human and teleost fish lineages about 450 million 
years ago. Therefore, comparisons of the human and cartilaginous fish genomes offer the 
highest stringency to identify highly conserved noncoding elements. Indeed, a 
comparison of the human genome with a 1.4× assembly of the elephant shark genome 
(comprising 134,109 scaffolds of average length 2.6 kb and covering ~75% of the 
genome) using the local alignment algorithm discontiguous MegaBLAST was able to 
identify about 5,000 highly conserved noncoding elements (≥100 bp long and ≥70% 
identical) (Venkatesh et al., 2006). Like the highly conserved human-fugu (Woolfe et al., 
2005) and human-zebrafish (Shin et al., 2005) elements, these human-elephant shark 
elements were found to be predominantly associated with transcription factor genes in the 
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human genome suggesting that they may function as cis-regulatory elements of 
transcription factor genes. However, an unexpected finding of this study was that the 
number of human-elephant shark elements was almost twice that identified in human-
fugu and human-zebrafish (Venkatesh et al., 2006). This implies that the regulatory 
regions of elephant shark are evolving slower than the regulatory regions of teleost fish 
and as such, elephant shark is a useful distantly related genome for identifying putative 
cis-regulatory elements in the human genome. However, the currently available highly 
fragmented assembly of the elephant shark precludes a comprehensive comparison of 
human and elephant shark genomes.  
 
In summary, whole-genome comparisons of human and distantly-related vertebrates have 
been effective in identifying a large number of highly conserved noncoding elements, and 
many of the conserved elements experimentally validated in vivo have been shown to 
function as cis-regulatory elements. However, whole-genome comparisons, particularly 
between distantly related genomes such as human and teleost fish, can fail to identify and 
align all the correct orthologous sequences. This is because the local alignment 
algorithms used are designed to be highly sensitive but less specific, and according to the 
scoring scheme and seeding strategy used, they will find all possible sequence 
similarities, not just the contiguous ones (Ureta-Vidal et al., 2003). Some of these 
methods were developed when the bulk of available sequences to be aligned were coding 
sequences, and it has been shown that such algorithms are not as efficient in aligning 
noncoding sequences (Bergman and Kreitman, 2001). Indeed a recent study measuring 
the accuracy of whole-genome local alignments at human Chromosome 1 showed that 
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misalignments tend to occur often in noncoding regions and become more prominent 
with increasing phylogenetic distance from humans, with the ambiguous alignments 
ranging from 3% in human-mouse alignments to almost 30% in human-zebrafish 
alignments (Prakash and Tompa, 2007). Therefore, a comprehensive and accurate 
alignment requires aligning the exact orthologous regions locus-by-locus using suitable 
global alignment algorithms.  
 
1.5.4 Alignment and visualization tools for comparative genomics 
A number of computational tools and web-based resources have been developed for 
comparing genomic sequences, locus-by-locus as well as whole-genomes, for discovering 
and visualizing putative cis-regulatory elements in the human genome. Identification of 
conserved elements by comparative genomics is generally a two-step process. First, 
orthologous regions of two or more different genomes are aligned at the nucleotide level 
so that for each nucleotide position in the reference genome, a best fit with the nucleotide 
at the respective position in the other genome(s) is determined. Second, based on this 
alignment, the different genomes are compared at the nucleotide level and statistical 
methods identify regions that are more constrained than would be expected for neutrally 
evolving DNA.  
 
Alignment algorithms generally fall into two categories: local and global alignment 
approaches. The commonly used local alignment programs include MegaBLAST (Zhang 
et al., 2000), discontiguous MegaBLAST (Ma et al., 2002), BLASTZ (Schwartz et al., 
2003), and MULAN (Ovcharenko et al., 2005). While the MegaBLAST, discontiguous 
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MegaBLAST and BLASTZ are pairwise alignment algorithms, MULAN is a multiple 
alignment program. Local alignment programs compute similarity scores between 
subregions of input sequences and are used when the input sequences vary in ways that 
prevent an accurate end-to-end alignment, for example when rearrangements, insertions 
or deletions are present in one or more sequences (Frazer et al., 2003). However because 
they do not take into account the region surrounding these matches, they can result in a 
false hit, for example detecting a paralogous sequence instead of the true ortholog (Visel 
et al., 2007). Pipmaker (http://bio.cse.psu.edu) is a worldwide web server that combines 
the use of the BLASTZ algorithm with a visualization of the aligned segments in 
comparing two long genomics sequences (Schwartz et al., 2000). A companion server at 
the same site called MultiPipmaker will align three or more genomic DNA sequences. 
Visualization of this alignment takes the form of a percent identity plot (“Pip”) displaying 
the position, length and percent identity (50-100%) of each gap-free segment in the 
pairwise BLASTZ alignments of the reference sequence with DNA from each of the 
other species.  
 
In contrast to local alignment algorithms, global alignment programs compute a similarity 
score over the entire length of input sequences, and are used for comparing sequences 
that are expected to share similarity over their entire length such as regions with 
conserved gene order and orientation, and are likely to be more sensitive in detecting 
highly divergent but orthologous regions in two contiguous sequences (Frazer et al., 
2003). They are less prone to return false-positive matches but fail to recognize 
homologous regions that have been locally rearranged by translocations or inversions 
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(Visel et al., 2007). Examples of global aligners are AVID (Bray et al., 2003), LAGAN 
(Brudno et al., 2003b), and MLAGAN (Brudno et al., 2003b). AVID looks for exact 
matches, limiting the comparison to closely related organisms, whereas LAGAN was 
designed to align both distantly and closely related organisms by using short inexact 
words, with level of degeneracy modified by the user. MLAGAN permits the multiple 
alignments of large genomic sequences. It involves a progressive alignment phase based 
on LAGAN, which first aligns the genomes of the most closely-related organisms, then 
incorporates the others in order of phylogenetic distance (Brudno et al., 2003b). 
MLAGAN has been found to perform better in multiple genome alignments containing 
distantly related genomes (Prakash and Tompa, 2007), and therefore is a useful tool in 
aligning and comparing mammalian and fish genomic sequences. Shuffle-LAGAN is a 
local-cum-global alignment program that has been specifically developed to find 
rearrangements during alignments and is useful to identify rearranged conserved 
noncoding sequences in related genomes (Brudno et al., 2003a). The VISTA server 
(http://www.gsd.lbl.gov/vista) is used to predict and display conserved noncoding 
sequences in the alignments generated first using the BLAT local alignment program and 
then globally aligned using AVID or LAGAN or MLAGAN (Frazer et al., 2003). VISTA 
plot visualizes pairwise global alignments between the reference sequence and DNA of 
other species by sliding a specified window (e.g., 100 bp) along each pairwise sequence 





1.6. Objectives of the present study 
The main aim of my project is to use a comparative genomics approach for identifying 
evolutionarily constrained noncoding elements associated with human genes known to 
express in the forebrain, and to systematically validate the function of elements 
associated with selected genes in transgenic mice using a β-galactosidase reporter 
construct. I chose the forebrain genes since the forebrain is one of the most complex 
organs in vertebrates. It comprises many structural and functional components, with a 
wide range of tissue types making up each component. Furthermore, the structure and 
development of forebrain is highly conserved across vertebrates making it an attractive 
system for using a comparative genomics approach. The forebrain arises from anterior 
neuroectoderm during gastrulation, and by the end of somitogenesis it comprises the 
dorsally positioned telencephalon and the more caudally located diencephalon (see Figure 
1). The dorsal telencephalon, or pallium, develops into the cerebral cortex, and the 
ventral telencephalon, or subpallium, becomes the basal ganglia, also known as the 
striatum. The diencephalon is primarily composed of the thalamus and the hypothalamus 
that is ventrally positioned (Figure 1). As such, forebrain morphogenesis is more complex 
than morphogenesis of other regions of the central nervous system. There are at least 
three major steps in the formation of the prospective forebrain. The ectodermal cells must 
acquire neural identity, the rostrally positioned neural tissue must adopt anterior 
character, and the regional patterning must take place within the rostral neural plate 
(Wilson and Houart, 2004). These steps result in a segment-like genetic organization of 
the forebrain, called the prosomeric model that attributes morphological meaning to 
known gene expression patterns and other data in the forebrain (Puelles and Rubenstein, 
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2003). In recent years it has become evident that several of the genetic mechanisms for 
establishing and patterning the vertebrate nervous system are conserved in insects 
(Kammermeier and Reichert, 2001) and annelids (Tessmar-Raible et al., 2007). However, 
despite the underlying homologies between vertebrate and invertebrate forebrains, the 
vertebrate forebrain is massively more complex. The vertebrate forebrain has been 
greatly expanded and shows evidence of compartmentalization not seen in other 
chordates, with the telencephalon known to be unique to vertebrates (Holland and 
Holland, 1999). Remarkably the general organization of the forebrain is conserved in all 
vertebrates including fish, reptiles, birds and mammals. What makes the brain of each 
species unique is not the initial presence or absence of different subdomains of the 
forebrain, but the way these domains are elaborated as they form the various structures 
that comprise the mature brain. Comparative studies in mammals, reptiles and fishes have 
shown conserved patterns of gene expression in the forebrain, suggesting homologies 
between regions in distant species (Broglio et al., 2005; Medina et al., 2005; Metin et al., 
2007). Studying the cis-regulatory elements associated with vertebrate forebrain genes 
should help to better understand the expression and developmental regulation of these 




Figure 1: Schematic diagram of the developing forebrain. The forebrain consists of the 
telencephalon and diencephalon. The telencephalon comprises the cerebral cortex (C) and 
striatum (S), while the diencephalon comprises the thalamus (Th) and hypothalamus 





Since my objective was to identify evolutionarily constrained noncoding elements, I 
chose to use fugu as a model for comparative genomics. The common ancestors of 
human and fugu diverged about 420 million years ago, and the noncoding sequences 
conserved in the two genomes over 840 million years of divergent evolution are likely to 
be under purifying selection. At 400 Mb, fugu genome is among the smallest vertebrate 
genomes (Brenner et al., 1993). It is about one-eighth the size of the human genome. 
However, fugu and human genomes contain a similar number of genes. The compaction 
has occurred mainly in the intergenic and intronic-regions which are typically short in 
fugu due to a paucity of repetitive elements (<10%). The short noncoding regions of fugu 
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reduces the noise to signal ratio in the prediction of conserved noncoding sequences and 
are useful for assaying the function of multiple putative cis-regulatory regions at the same 
time. Additionally, fugu genome was the second vertebrate genome to be completely 
sequenced (Aparicio et al., 2002), the first being that of human (Lander et al., 2001; 
Venter et al., 2001). The availability of the whole genome sequence of the compact fugu 
genome has made it an attractive fish model genome for comparative studies for 
identifying cis-regulatory elements. Although whole genome comparisons of human and 
fugu have been carried out, such comparisons can fail to identify and align all the exact 
orthologous sequences, particularly between distantly related genomes like human and 
fish. Furthermore genome-wide comparisons are predicted to contain up to 25% 
misalignments between human and fugu (Prakash and Tompa, 2007). On the other hand, 
locus-by-locus comparison of orthologous sequences would be more effective in 
identifying all the associated CNEs, and the use of global alignment algorithms here 
would have more power in detecting weakly conserved regions than local alignments 
(Frazer et al., 2003).  
 
To make a comprehensive search for cis-regulatory elements, I carried out a locus-by-
locus alignment of human, mouse and fugu genes using MLAGAN. Multiple alignments 
of human-mouse-fugu were found to be better than pairwise fugu-human alignments in 
anchoring the alignment seeds, and thereby detecting conserved regions with higher 
specificity (Alison Lee and B.Venkatesh, unpublished data). Among the global alignment 
programs, MALGAN has been shown to be adept in identifying CNEs with relatively 
high specificity (Prakash and Tompa, 2005). For this project, I selected at random 50 
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human genes that are known to express in the forebrain and whose regulation has not 
been elucidated. From among the genes containing conserved noncoding elements, three 
genes representing different levels in the hierarchy of the gene regulatory network were 
selected and the function of the CNEs associated with them were systematically assayed 














       
Chapter 2 
 




2.1 Genomic sequence alignment and prediction of conserved noncoding sequences  
Human genes for this study were selected by searching the Pubmed database 
(http://www.ncbi.nlm.nih.gov/sites/entrez) using key words such as “forebrain”, 
“transcription factor” and “development” to look for genes known to express in the 
developing forebrain, and whose regulation had not yet been well understood. The 
protein and nucleotide sequences for the genes were retrieved from Ensembl 
(http://www.ensembl.org/index.html). The mouse and fugu orthologs for these genes 
were identified from Ensembl BioMart and their sequences were also retrieved from 
Ensembl. BioMart typically identifies a single ortholog in mouse and fugu. However, 
fugu contains duplicate genes for many human genes due to a ‘fish-specific’ whole 
genome duplication (Christoffels et al., 2004). In order to identify duplicate fugu 
orthologs, if any, for the human genes selected for this study, I searched using a 
combination of data from Ensembl Biomart (fugu version 4 assembly) and 
INPARANOID analysis. INPARANOID has been used to identify duplicate fugu 
orthologs for human forebrain genes that may have been missed in Ensembl and these 
orthologs have been made available in the public domain on the human-fugu synteny 
viewer (http://humpback.bii.a-star.edu.sg/fugu-synteny/viewer.php) (Mohamad Hirwan 
and B. Venkatesh, unpublished).  
 
The genomic sequences, comprising the entire 5’ and 3’ flanking regions, for each of the 
human, mouse and fugu genes were retrieved from Ensembl. The use of global alignment 
algorithms here would have more power in detecting weakly conserved regions than local 
alignments (Frazer et al., 2003) and among the global alignment programs, MALGAN 
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has been shown to be adept in identifying CNEs with relatively high specificity (Prakash 
and Tompa, 2005).The sequences of the orthologous human, mouse and fugu gene loci 
were therefore aligned using the global alignment algorithm MLAGAN 
(http://genome.lbl.gov/vista/lagan/) using fugu as the reference sequence. Reverse 
complementation of sequences was necessary to harmonize sense and antisense 
sequences prior to upload. The conserved noncoding elements (CNEs) were predicted 
and visualized using VISTA (http://genome.lbl.gov/vista/index.shtml). Annotation files 
of the fugu reference sequence were obtained from Ensembl to achieve the VISTA plots 
showing exon structure of the reference gene. The CNEs between human and mouse are 
generally predicted using the criterion equal to or greater than 70% identity over 100 bp 
or more (Loots et al., 2000) or  greater than 60% identity over 50 bp of sequence.  
 
In order to exclude any coding sequences among the CNEs that were missed in the 
genome annotation, I searched the CNEs using BLASTX against NCBI’s non-redundant 
protein database and the significant matches (E-value <10-4) were eliminated. The 
remaining CNEs were searched using both BLASTN (E-value <10-4) and INFERNAL 
searches against the Rfam database (Release 7.0) and miRNA registry (Release 8.0), and 
those containing RNA sequences were excluded from further analysis. The final set of 
CNEs should comprise mainly transcriptional enhancers, chromatin structural sequences 
and other regulatory elements.  
 
The functional categories of the forebrain genes were determined by identifying the Gene 
Ontology (http://www.geneontology.org/) terms associated with them. The transcription 
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factor (TF) binding sites in CNEs were predicted using the program TESS (transcription 
element search system) (http://www.cbil.upenn.edu/cgi-bin/tess/tess). TF binding sites 
are usually short (6-15bp) sequences with degeneracy at several positions, and hence 
TESS predictions may contain many false positives. In order to reduce the number of 
false positives, only those binding sites that showed 90% identity to known binding sites 
in the TRANSFAC database and were totally conserved in all the three genomes (human, 
mouse and fugu) were retained. 
 
2.2 Generation of DNA constructs for microinjection 
The functions of individual CNEs were assayed by linking them to their basal promoter 
and a β-galactosidase reporter. The β-galactosidase reporter vector, pnlacF (Mercer et al., 
1991) was constructed by Jacques Peschon and kindly supplied by Richard Palmiter from 
Howard Hughes medical institute, Washington, USA. The basal promoter and individual 
or clusters of CNEs were amplified by PCR using mouse genomic DNA or fugu genomic 
DNA as a template. The PCR primers for the basal promoters (690 to 860 bp) contained 
restriction sites for XbaI upstream and SalI downstream. The PCR amplicon was 
fractionated on a TAE agarose gel and excised from the gel and purified by the 
Geneclean II kit (Qbiogene, USA). The purified product was digested with XbaI and SalI 
enzymes and cloned into the respective cloning sites of the pnlacF vector. The primers 
for amplifying CNEs (ranging from 220-740 bp in size) contained restriction site for 
KpnI upstream and downstream, and amplicons included about 100 bp of sequence on 
either side of the CNEs.  The CNE-PCR amplicons were digested with KpnI and cloned 
into the KpnI site upstream of the basal promoter in the lacZ+promoter construct. The 
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orientation and sequences of the inserts (promoter and CNEs) were verified by 
sequencing on an ABI3730xl (Applied Biosystems, USA) automated DNA sequencer 
using the big dye terminator chemistry. 
 
2.3 Isolation and sequencing of fugu cosmid to map the orexin locus 
The latest assembly of the fugu draft genome sequence (http://www.fugu-sg.org) contains 
7213 scaffolds spanning 393 Mb. The fugu scaffold (#424; 131 kb) containing the orexin 
gene was identified by TBLASTX search using human prepro-orexin cDNA sequence. 
Searching the fugu scaffold sequence against the non-redundant protein database at the 
National Center for Biotechnology Information (NCBI) using BLASTX algorithm 
confirmed that it contained a homolog of human orexin (ORX) gene. The other genes on 
the scaffold were identified and annotated in a similar way based on their homology to 
sequences in the NCBI database. The information about the order and orientation of 
genes at the human and mouse ORX loci was obtained from the UCSC genome browser 
at http://www.genome.ucsc.edu. Alignment of Fugu and mammalian ORX sequences was 
performed by Megalign (DNAStar) using the ClustalW algorithm with Gonnet 250 
protein weight matrix, and gap penalty of 10.  
 
The fugu scaffold sequence surrounding the ORX gene contained several gaps. To fill the 
gaps and to make constructs for transgenic studies, I isolated fugu cosmids for this locus. 
A fragment of the fugu ORX locus (680 bp of exon 1, intron1 and exon2 amplified by 
PCR using the primer pairs forward: 5’- CAG AAA GGC ACG AGG ATG TCC-3’ and 
reverse: 5’- GTT TGCCCA GCG TGAGGA TGC -3’) was used to probe a fugu cosmid 
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library (Greg Elgar, UK HGMP Resource Center). Altogether 10 positive cosmids (19J5, 
33B9, 40H16, 106I3, 117J20, 132F24, 151I10, 173F1, 199L2 and 199L3) were isolated. 
The end sequences of the cosmids were determined using primers complementary to the 
cosmid arm on an automated DNA sequencer and compared to the fugu scaffold 
sequence. Cosmid 33B9 with an insert size of about 39 kb was selected as a 
representative clone for sequencing. The fugu scaffold sequence spanning this cosmid 
contained ten gaps ranging from 50 bp to 1 kb. The gaps were filled by directly 
sequencing the cosmid DNA using primers flanking the gaps. Transgenic constructs were 
made by deletions of this cosmid using appropriate restriction enzymes. 
 
2.4 Generation of transgenic mice 
The mouse strains used were as follows: the embryo donors were FVB/N F1 mice and 
pseudo pregnant recipients were B6CBA F1 mice. Mice were cared for in accordance 
with National Institutes of Health (NIH), USA guidelines. Transgenic mice were 
generated essentially as described by Murphy and Carter (1993). Briefly, clean linearized 
DNA was microinjected into single-cell embryos and implanted into the pseudo pregnant 
mothers. At different embryonic developmental stages, the mothers were sacrificed to 
harvest the embryos for analyzing the expression of the introduced transgene. Embryo 
sacs or yolk sacs were used for genotyping to identify founders. For orexin constructs, the 
transgenic mice from the microinjected embryos were allowed to mature to 3 weeks old, 
and then tail clipped and genotyped to identify founders. Founders were then crossed in a 
series of breeding experiments to generate transgenic lines of mice, individuals of which 
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were then analyzed for expression of the introduced transgenes. At least 3 founder lines 
of transgenic mice were generated for each construct.  
 
2.5 Preparation of DNA for microinjection 
The DNA has to be cleaned of a number of contaminants that can kill the embryos, 
particularly excess EDTA and endotoxin (bacterial lipopolysaccharide). Transgenics are 
generated with linear DNA with the naked ends acting as substrate for nonhomologous 
end joining to be incorporated into the host genome. Cosmid and plasmid DNA meant for 
microinjection were prepared with silica-based miniprep columns (Promega, USA). 
Miniprepped DNA was linearized with appropriate restriction enzymes. Vector sequences 
were removed to minimize rearrangement of transgenes in the nuclei of the embryos. If 
the clone was a plasmid, it was fractionated on an agarose gel to separate the insert from 
the vector. The insert DNA was extracted from the agarose gel using sodium iodide 
solution (Geneclean II kit, Qbiogene, USA). If the clone was a cosmid, then the 
restriction digest was purified directly on a silica-based miniprep column (Qiagen, USA). 
The DNA was quantified and diluted to 4 ng/μl using ‘microinjection TE’ (10 mM Tris 
pH 8, 0.1 mM EDTA), filtered (0.2 μm disposable filter, Sartorius, Germany) and then 
submitted to the Biological Resource Centre of Biopolis, Singapore who carries out 
microinjection for researchers as a core service.  
 
Briefly, the process leading up to microinjection as performed by the Biological Resource 
Centre is as follows. 3-week old FVB/N female mice are superovulated with 10 IU of 
pregnant mare’s serum (Sigma-Aldrich, USA) followed by 10 IU of human chorionic 
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gonadotrophin (Sigma-Aldrich, USA) 46 to 48 hours later. They are then mated with 3 to 
6-month old FVB/N stud males and the following morning the mated females are 
checked for ‘ovulatory plugs’. Presence of the ovulatory plugs on the mice is taken to be 
signs of successful mating. The plugged females are sacrificed using carbon dioxide and 
the oocyte-cumulus complex (OOC) is then surgically retrieved from the ampulla of the 
oviduct in M2 medium (Sigma-Aldrich, USA). The oocytes are further released from the 
oocyte-cumulus complex using hyaluronidase (Sigma-Aldrich, USA). The oocytes are 
then cultured in M16 medium (Sigma-Aldrich, USA) and covered with mineral oil 
(Sigma-Aldrich, USA) in a 5% CO2 incubator at 37oC. During microinjection of DNA, 
DNA is introduced into one of the pronucleus of two-pronuclear embryos under 400x 
magnification using Leica micromanipulator with Nikon 2000 Eclipse microscope. 
Embryos that have survived DNA injection are transferred into the oviducts of CBAB6F1 
pseudo pregnant female mice. These mice are then handed over to me to sacrifice at the 
appropriate developmental stages to harvest transgenic embryos, or allowed to give birth 
to produce transgenic lines for mating. 
 
2.6 Genotyping 
Mice about three weeks old were ear clipped for identification and about 5 mm of tail 
taken for genotyping. If embryos were harvested, yolk sacs or embryos sacs of the same 
size were removed for genotyping. The tail clip or sac was digested in 300 μl of tail 
digestion buffer (50 mM Tris pH 8, 100 mM NaCl, 10 mM EDTA, 0.1% SDS, 0.4 mg/ml 
proteinase K) at 55oC for at least three hours. An equal volume of isopropanol was then 
added and the mixture shaken vigorously for ten seconds. This would cause the DNA to 
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quickly appear as a stringy white precipitate. The precipitate was immediately spun down 
at 14,000 g for two minutes in a bench top centrifuge, the supernatant discarded and 70% 
ethanol was added to wash the pellet. This was again spun down for five minutes, the 
supernatant tipped off and the remainder spun down for five seconds and pipetted out. 
The pellet was dried for three minutes in a vacuum, then dissolved with vigorous 
vortexing in 40 μl TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0). The DNA 
concentration was consistently about 1.0-1.2 μg/μl. The DNA can be genotyped either by 
PCR or Southern blotting. Initially I performed both procedures and because they gave 
consistent results, I continued with PCR as the preferred way of genotyping.  
 
For Southern blotting, briefly 10 μl of each DNA sample was digested with 20-30U of a 
restriction enzyme for 1-2 hours at 37oC, and then fractionated on a 0.5-1.0% TBE 
agarose gel (Invitrogen, USA). The gel was agitated in transfer / denaturation solution 
(1.5M NaCl, 0.25M NaOH) for 15 minutes. The DNA in the gel was then transferred (for 
three hours to overnight) from the gel to a HybondN nylon membrane (Amersham, 
United Kingdom) by capillary transfer. After the transfer, the position of the wells was 
marked on the membrane, and the membrane was rinsed in 2 x SSC (20 x SSC contains 
3M NaCl and 0.3M TriNaCitrate) for 30 seconds. The DNA was then cross-linked in the 
UV cross linker (Stratalinker, Stratagene, USA). The membrane was prehybridized for 20 
minutes in Church and Gilbert solution (0.25M Na2HPO4 adjusted to pH 7.4 with 
orthophosphoric acid; 7% SDS; 1mM EDTA). The purified probe was prepared by 
running either a PCR reaction or a digested plasmid on TAE gel, excising the desired 
band and extracting it using the Geneclean II kit. This probe is then melted to single-
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stranded DNA and labeled with [α-32P]dCTP using the Random Labeling kit 
(Boehringer-Ingelheim, Germany). The labeled and purified probe was denatured by 
boiling at 100oC for 5 minutes and hybridized to the membrane overnight. Next morning 
the membrane was rinsed with wash solution (2 x SSC, 0.1% SDS) to remove excess 
probe, then washed twice for 15 minutes each. This was usually sufficiently stringent for 
genotyping. The membrane was then blotted on paper towels, wrapped in Saran wrap and 
exposed to X-ray film.  
 
PCR genotyping was conducted with lacZ-specific primers (forward primer: 5’-TTT 
CCA TGT TGC CAC TCGC -3’; reverse primer: 5’-AAC GGC TTG CCG TTC AGCA -
3’). The conditions comprised a denaturation step at 95oC for 2 min, 35 cycles of primer 
annealing and extension: 95oC for 30 sec, 60oC for half a min, 72oC for 1 min, followed 
by a final elongation step at 72oC for 5 min. The PCR reaction mixture was carried out in 
a volume of 20 μl consisting of 1x PCR buffer (i-DNA biotechnology, Singapore); 0.2 
mM of each dNTP (Amersham, United Kingdom), 0.2 μM of each primer (1st Base, 
Singapore) and 1 U of Taq polymerase (i-DNA biotechnology, Singapore). The PCR 
products were analyzed by agarose gel electrophoresis using a 1 kb ladder (Invitrogen, 
USA) as a marker, and transgenic lines were identified by the presence of a 374 bp band. 
 
2.7 In situ hybridization  
2.7.1 Preparation of embryos and tissues for whole-mount or section in situ 
hybridization 
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Instead of β-galactosidase staining, I employed the more sensitive technique of in situ 
hybridization to detect the mRNA of the lacZ reporter transgene in mouse embryos and 
tissue sections. Mice were killed by cervical dislocation or carbon dioxide gassing. 
Mouse embryos were harvested from a range of 8.5 to 15.5 days post coitum (E8.5-
E15.5) and dissected in 1 x DEPC-treated PBS, pH 7.4. Individual yolk sacs were 
dissected out and collected for genotyping while the embryos were transferred into 
freshly prepared 4% paraformaldehyde (Sigma-Aldrich, USA) in DEPC-treated PBS in 
6-well or 12-well or 24-well Nunclon (Apogent, Denmark) cell culture plates using 
sterile disposable pipettes. Briefly, 4% paraformaldehyde solution was prepared by 
dissolving the powder in 1 x DEPC-treated PBS and heating it to about 60oC on a hot 
plate with gentle stirring in a fume hood. A few drops of 10M NaOH were added until the 
solution is completely clear, and pH is adjusted to 7.4 with HCl. For convenience, 20% 
paraformaldehyde in PBS stock solutions were made and frozen at -20oC, ready to be 
diluted for use. After transfer, the wells were examined to ensure the embryos (especially 
the smaller E9.5-E10.5 ones) were not floating on the surface of the fixative where they 
would be destroyed or damaged by surface tension; if so additional fixative was used to 
cause the embryos to sink. Embryos were fixed for 3 hours to overnight with gentle 
shaking at 4oC. Smaller embryos (E8.5-E11.5) were then dehydrated through a methanol 
(MeOH) series: 25% MeOH / 75% PBT (1 x DEPC-treated PBS, 0.1% Tween 20), 50% 
MeOH / 50% PBT, 75% MeOH / 25% PBT, and then twice in 100% MeOH, each for 5 
minutes. These were then stored in -20oC in 100% MeOH until ready for hybridization.  
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After fixing, larger embryos (E13.5-E15.5) were transferred to 30% sucrose (BDH, Great 
Britain) dissolved in DEPC-treated water and incubated with gentle shaking until all the 
embryos sank to the bottom of the well; this may take up to two days. The rehydrated 
embryos were then beheaded and the heads embedded in OCT mounting medium (Sakura 
Finetek, USA) in plastic boats (Polysciences Inc, USA), and the boats were placed in dry 
ice/ethanol bath until they were frozen through. The same procedure was applied when 
harvesting tissues from adult mouse. Briefly, these tissues were first fixed in 4% 
paraformaldehyde, then rehydrated in 30% sucrose and finally embedded in OCT 
medium in plastic boats. The orientation in which the tissue is embedded depends on the 
kind of section that will be taken. These tissue containing OCT blocks in the plastic boats 
were then stored in the -80oC freezer until ready for sectioning. 
 
Sectioning of tissues was carried out in a cryostat (Leica, USA). 10 to 20 μm sections 
were cut from the OCT blocks at -18oC to -20oC, and thaw mounted onto polysine coated 
slides (Menzel-Glaser, Erie Scientific Company, USA). The slides were left to dry on a 
heat block at 37oC for about an hour after sectioning, then stored in a slide box and kept 
in the -80oC freezer until the hybridization. 
 
2.7.2 Synthesis of RNA probes for in situ hybridization 
To create a template for riboprobe synthesis, the probe insert of about 300-400 bp in size 
was cloned into a pBluescript vector (Stratagene, USA) with a ‘T’ overhang, that 
contained a T3 and T7 promoter sites, and the vector was linearized by EcoR1 or HindIII 
respectively to create a 5’ overhang. After enzyme digestion, the DNA was precipitated 
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with 0.1 volume 3 M NaOAc and 2.5 volumes 100% ethanol, washed with 70% ethanol 
and resuspended in 40 μl TE buffer (pH 8.0) at a final concentration of 1 μg/μl. 
Riboprobe synthesis was then carried out as follows using a non-radioactive label: To a 
final volume of 20 μl, add 1 μl template (1 μg), 4 μl of 5x transcription buffer (Roche, 
Germany), 2 μl of digoxygenin (DIG) or fluorescein (FITC) RNA labeling mix (Roche, 
Germany), 1 μl of RNase inhibitor (Roche, Germany) and 40 units of T3 or T7 
polymerase (Roche, Germany). The mixture was incubated at 37oC for 2-3 hours, then 
treated with 1 μl of RNase-free DNase I (10 units/ul; Roche, Germany) and incubated at 
37oC for 15 minutes. Probe synthesis was checked by running a 2 μl sample on a 1% 
agarose gel. RNA was then precipitated by the addition of 2 μl 0.5M EDTA (pH 8.0), 5 
μl of 4M LiCl and 125 μl of 100% ethanol and incubated at -80oC overnight. On the next 
day, RNA was spun down at 14,000 g for 30 minutes at 4oC, the pellet washed with cold 
70% ethanol and air-dried briefly. RNA was then resuspended in 30-50 μl DEPC-treated 
water (depending on the size of the pellet) and stored at -80oC. 
 
2.7.3 Pretreatment of embryos and sections 
Embryos (8.5-11.5 dpc) were rehydrated through 75% MeOH / 25% PBT, 50% MeOH / 
50% PBT, 25% MeOH / 75% PBT and finally twice in PBT, with 5 minutes for each 
wash. Using a 27 G needle, punctures were made in the head and trunk of E10.5 and 
E11.5 embryos to facilitate the penetration of the various reagents and probe. Embryos 
were then bleached with 6% H2O2 (diluted in PBT from fresh 30% concentrated stock) 
for 1 hour at room temperature, and washed three times with PBT for 5 minutes each. 
Embryos were then permeabilized with proteinase K (Roche, Germany) diluted in PBT at 
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room temperature, for the appropriate length of time depending on their stage, and 
observed under the microscope. Proteinase K treatment was stopped by adding freshly 
prepared 2 mg/ml glycine in PBT for 10 minutes at room temperature, then washed twice 
with PBT for 5 minutes each. Embryos were then postfixed with freshly made 4% 
paraformaldehyde / 0.2% glutaraldehyde (Sigma-Aldrich, USA) in PBT for 20 minutes at 
room temperature, followed by two PBT washes, before being transferred into 
prehybridization solution in 1.5 ml or 2 ml eppendorf tubes, depending on the size and 
number of embryos used. The prehybridization solution comprised 50% formamide 
(Invitrogen, USA), 5x SSC pH 4.5, 50 μg/ml yeast tRNA (Roche, Germany), 1% SDS 
(BDH, Great Britain) and 50 μg/ml heparin (Sigma-Aldrich, USA) all dissolved in 
DEPC-treated water. Prehybridization was carried out at 70oC in a water bath for at least 
an hour. 
 
Slides were pretreated as follows: 4% paraformaldehyde in DEPC-PBS was prepared as 
described previously and added to Coplin jars (Analytical technology, USA; each can 
hold up to 10 slides and a liquid volume of 25-30 ml), and the slides were transferred 
directly from the freezer to the jars. Fixing took place for an hour at room temperature. At 
the end of this incubation, the solution was tipped out of the jar and the slides were 
washed with DEPC-treated PBS three times, 5 minutes each. The next solution 0.2% 
Triton X in DEPC-treated PBS was freshly made and added for an incubation of 10 
minutes, followed by another three washes of PBS. Slides were then incubated a third 
time for 10 minutes with acetic anhydride solution of pH 8.0 that comprised 390 μl of 
triethanolamine (Sigma-Aldrich, USA) and 75 μl of acetic anhydride stock (Sigma-
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Aldrich, USA) in 30 ml of DEPC-treated water. After washing three times with PBS, 
slides were arranged face up in a humidified chamber and sufficient (100-200 μl) pre-
hybridization solution (Dako, Denmark) was added to cover all the sections in each slide. 
In addition, parafilm was added onto each slide to ensure the sections did not dry up. The 
chamber was then placed in an oven at 55-58oC for at least two hours. 
 
2.7.4 Hybridization, washing and antibody addition 
The prehybridization solution in the Eppendorf tubes containing the embryos was 
replaced with fresh hybridization solution containing 1 μg/μl riboprobe (ratio is about 1 
μl probe: 400 μl hybridization solution). Tubes were then inverted a few times gently to 
mix the probe, sealed with tape or parafilm, and submerged in a water bath at the same 
temperature of 70oC overnight. On the next morning, embryos were rinsed with freshly 
made Solution 1 (50% formamide, 4x SSC at pH 4.5 and 1% SDS) and washed three 
times at 70oC for 30 minutes each. Tubes were inverted often to mix and to ensure 
embryos did not stick to the walls. New tubes were used after the first round of wash. A 
second series of three washes with freshly made Solution 2 (50% formamide, 2x SSC at 
pH 4.5) was then carried out at 65oC for 30 minutes each. Following this, embryos were 
transferred to a 6-well or a 12-well plate (depending on the number of tubes) and washed 
in TBST (1x TBS diluted from a 10x TBS stock that comprised 0.5M Tris Base and 9% 
NaCl at pH 7.6; 0.1% Tween 20; 2 mM levimasole (Sigma-Aldrich, USA)) three times at 
room temperature for 5 minutes each, with gentle shaking. Embryos were then incubated 
in blocking reagent (Boehringer Ingelheim, Germany) dissolved in TBST and containing 
10% heat-inactivated sheep or horse serum (Gibco, Invitrogen, USA) for at least an hour 
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at 4oC with shaking, before being replaced by a new aliquot of blocking solution 
containing the pre-absorbed antibody labeled with alkaline phosphatase (AP) and directed 
to DIG (Roche, Germany) at 1:2000 concentration ratio and left to shake overnight at 
4oC. 
 
After hybridization overnight in the humidified chamber, the parafilm was removed and 
the slides were transferred back into Coplin jars and washed twice in 1x SSC / 0.1% 
Tween 20 for 5 minutes at room temperature. The second round of washes was carried 
out using 1x SSC / 50% formamide for two washes at 20 minutes each at 60oC. A third 
round of two washes used 0.2x SSC / 0.1% Tween 20 at 60oC for 20 minutes each. The 
final round of washes was in 1x PBS / 0.1% Tween 20 at room temperature for two 
washes at 5 minutes each. The slides were then taken out of the jars, excess fluid was 
tipped off (without allowing the slides to dry), and were arranged face-up in the 
humidified chamber again. Blocking agent dissolved in 1x Maleic acid (Sigma-Aldrich, 
USA) was added in excess to each slide, covered with parafilm and left at room 
temperature for at least an hour. Following this, blocking agent was tipped off and fresh 
blocking buffer was added that contained antibody either labeled with AP or horseradish 
peroxidase (HRP) and directed to DIG or FITC (Roche, Germany) at a concentration of 
1:500, and slides were incubated in the chamber at room temperature for about 2 hours or 




After antibody detection, embryos were washed with TBST at room temperature for the 
whole third day, initially three times for 5 minutes each, and then five times for 1 hour or 
more each time, before being left to shake overnight at 4oC. On the fourth day, embryos 
were washed in NTMT (100 mM NaCl, 100 mM Tris-HCl at pH 9.5, 50 mM MgCl2, 
0.1% Tween 20, 2mM levimasole) for three times at room temperature at 10 minutes 
each. Embryos were then transferred to cavity dishes and detection solution containing 20 
μl NBT / BCIP (Roche, Germany) in 1 ml NTMT and 10% polyvinyl alcohol (Sigma-
Aldrich, USA) was added to each dish and kept in the dark. NTMT containing 10% 
polyvinyl alcohol was heated to 70oC with stirring until the polyvinyl alcohol was 
completely dissolved, before being cooled down to room temperature and then the 
NBT/BCIP mix was added. Polyvinyl alcohol significantly increases detection 
sensitivity. The progress of the staining reaction was monitored at hourly intervals using 
a dissection microscope. Staining reaction was stopped by washing embryos twice with 
PBT at pH 5.5, then postfixing embryos for 1 hour with freshly made 4% 
paraformaldehyde / 0.1% glutaraldehyde in PBS, followed by washing three times with 
PBS. Embryos were then cleared for visualization of signals by shaking in 50% glycerol 
(Invitrogen, USA) / PBS for 30 minutes, followed by 80% glycerol / PBS for 30 minutes 
before storing in 100% glycerol at 4oC until ready for photography. 
 
For detection of signals in tissue sections, the antibody mix covering each section was 
tipped off and slides were transferred back to the Coplin jars and washing was carried out 
using TBST for three washes at 10 minutes each. Slides were then rinsed with AP-
detection buffer (100 mM NaCl, 100 mM Tris-HCl at pH 9.5, 50 mM MgCl2) three times 
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at 5 minutes each. Following this, NBT / BCIP was mixed with the detection buffer as 
described before and added to each slide in excess (150-200 μl per slide). The slides were 
allowed to develop in the dark in the humidified chamber, and the staining reaction which 
could take 10 minutes to several hours to develop, was monitored under a microscope at 
regular time intervals. Staining was stopped by rinsing in MilliQ water and slides were 
washed three times for 5 minutes each. Slides were then mounted using crystal mount, 
left to dry and stored at 4oC in a humidified chamber until ready for photography. 
 
2.8.6 Double in-situ hybridization 
Double in situ hybridization was carried out to show colocalization of the endogenous 
gene and transgene in the same cell type. Slides were pretreated as described above, and 
during hybridization, both probes were added together on the same slide. Washing was 
carried out the next day as described. Both antibodies used for probe detection were then 
added together on the same slide. One was directed to DIG and labeled with AP (Roche, 
Germany), while the other antibody was directed to FITC and labeled with HRP (Roche, 
Germany). The visualization stage was carried out in two steps. First, the signal attributed 
to the FITC-specific probe was developed using DAB solution (0.02% (w/v) 3, 3'-
diaminobenzidine tetrahydrochloride (DAB) and 0.005% (v/v) H2O2 in 0.05 M Tris-HCl 
buffer, pH 7.6) that produced a brown signal that is not soluble in water. Following this, 
slides were rinsed in AP-detection buffer described above for three times at 5 minutes 
each, and the DIG-labeled probe signal was developed using the Nuclear Fast Red 
reagent (Sigma-Aldrich, USA) or the Vector Blue reagent system (Vector Laboratories, 
















      Results 





Comparative genomics is a powerful approach for identifying functional noncoding 
sequences in the human genome. Orthologous noncoding sequences that are highly 
conserved over long evolutionary periods are most likely to be functional elements that 
are under purifying selection. Such elements include transcriptional enhancers, RNA 
genes; splicing regulatory elements; sequences conferring structural chromatin features; 
and sequences playing a role in chromosomal replication and recombination. The main 
focus of my project is to use a comparative genomics approach for identifying gene 
regulatory elements associated with forebrain genes in the human genome. I chose fugu 
as a model for comparison because of its maximal evolutionary distance from the human 
genome (~420 Myr) and its compact intergenic and intronic sequences. I first chose a set 
of 50 human genes at random that are known to express in the forebrain and whose 
regulatory mechanisms have not been well characterized. Although whole genome 
comparisons of human and fugu have been carried out, such comparisons can fail to 
identify and align all the exact orthologous sequences, particularly between distantly 
related genomes like human and fish. On the other hand, locus-by-locus comparison of 
orthologous sequences using a global alignment program is more effective in identifying 
all the conserved non-coding elements (CNEs) including the weakly conserved regions 
(Frazer et al., 2003). In this study, sequences for the orthologous gene loci from human, 
mouse and fugu genomes were systematically extracted and compared locus-by-locus 




3.2 Identification of human, mouse and fugu forebrain genes 
Human forebrain genes for this study were selected by searching the Pubmed database 
(http://www.ncbi.nlm.nih.gov/sites/entrez) using a combination of key words such as 
“human”, “forebrain”, “gene expression” and “gene regulation”, and by reading the 
relevant publications. The list of the human forebrain genes selected is given in Annex I. 
The nucleotide sequences encompassing the entire 5’ and 3’-flanking sequences of these 
genes were retrieved from Ensembl (http://www.ensembl.org/index.html). The mouse 
and fugu orthologs for these genes were identified using reciprocal BLAST and 
INPARANOID (see Materials and Methods). Of the 50 human forebrain genes I started 
with, all 50 have orthologs in mouse and fugu, with fugu containing two orthologs (“co-
orthologs”) for 8 of the genes. These co-orthologs in fugu are likely to be the result of a 
whole-genome duplication in the fish lineage (Christoffels et al., 2004; Vandepoele et al., 
2004). 
 
3.3 Prediction of CNEs  
The orthologous genomic sequences, comprising the entire 5’ and 3’ flanking regions, for 
each of the human, mouse and fugu genes were aligned using the global alignment 
algorithm MLAGAN (http://genome.lbl.gov/vista/lagan/) using fugu as the reference 
sequence. Consistent with its compact genome size, the fugu loci were about one-eighth 
the size of the human and mouse loci. The CNEs between human and mouse are 
generally predicted as sequences that exhibit a minimum of 70% identity across 100 bp or 
more (Loots et al., 2000). However, in human and fish comparisons, considering the 
longer evolutionary distance between these two lineages, a less stringent criterion of a 
 53 
minimum 60% identity across 40 bp or more has been used for defining human-fish 
CNEs. Indeed, a significant proportion of human-fish CNEs predicted using these criteria 
has been found to function as transcriptional enhancers directing tissue-specific 
expression during in vivo assays (Sanges et al., 2006; Woolfe et al., 2005). Therefore I 
decided to use the threshold values of 60% identity and 50 bp window sizes for 
identifying mammal-fugu CNEs in the 50 forebrain genes. 
 
Altogether a total of 206 CNEs with a combined length of 30 kb were identified (Table 
1). The average length of these CNEs is 139 bp, with the largest CNE spanning 1024 bp. 
Slightly more than half of the CNEs (107 CNEs) were located in the 5’ intergenic regions 
while about a quarter (61 CNEs) were located in the 3’ intergenic region with the rest 
distributed in the introns. A representative VISTA plot of a MLAGAN alignment is 






Figure 2: Identification of CNEs in Otp locus in human, mouse and fugu. VISTA plot 
of the MLAGAN alignment is shown. The human and mouse loci span 200 kb and 133 
kb respectively while the fugu locus is 45 kb long. The MLAGAN alignment was 
generated using fugu as the base sequence. Peaks represent conserved sequences; coding 
sequences are shaded purple and non-coding sequences (CNEs) are shaded pink. The 9 
CNEs identified are shown inside red rectangle boxes. X-axis represents fugu sequence 
and Y-axis represents percent identities (50%-100%). 
 
 55 
Table 1: List of 50 forebrain genes with the number and total length of CNEs 
associated with each gene.  
 
No Gene description Symbol No. of CNEs Length of CNEs (bp) 
1 Empty spiracles homeobox 1 EMX1 0 - 
2 Aristaless related homeobox ARX 9 1054 
3 Ventral anterior homeobox 1  VAX1 2 490 
4 Orthodenticle homeobox 1 OTX1 3 265 
5 Retina and anterior neural 
fold homeobox 
RAX 1 58 
6 Orthopedia homeobox OTP 13 2020 
7 GS homeobox 1 GSH1 4 1707 
8 GS homeobox 2 GSH2 6 1509 
9 Paired-like homeodomain 2 PITX2 16 2398 
10 Sine oculis-related 
homeobox homolog 3 
SIX3 14 1910 
11 Sine oculis-related 
homeobox homolog 6 
SIX6 3 278 
12 Cartilage paired-class 
homeoprotein 1 
CART1 0 - 
13 LIM homeobox 2 LHX2 1 58 
14 LIM homeobox 5 LHX5 6 627 
15 LIM homeobox 6 LHX6 3 201 
16 LIM homeobox 8 LHX7/ 
LHX8 
1 50 
17 POU class 3 homeobox 3 BRN1/ 
POU3f3 
22 2765 
18 POU class 3 homeobox 2 BRN2/ 
POU3f2 
5 590 
19 Transducin-like enhancer of 
split 1 
TLE1 1 50 
20 Single-minded homolog 1 SIM1 0 - 
21 T-box brain gene 1 TBR1 1 70 
22 Eomesodermin homolog TBR2/ 
EOMES 
1 81 
23 Cellular nucleic acid binding 




24 FEZ family zinc finger 2 FEZF2/ 
ZFP312 
9 708 
25 Zinc finger protein of the 
cerebellum 2 
ZIC2 4 591 
26 GLI-Kruppel family member 
isoform 2 
GLI2 9 899 
27 GLI-Kruppel family member 
isoform 3 
GLI3 22 3258 
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28 Forkhead box G1 BF1/ 
FOXG1 
4 335 
29 Forkhead box B1 FOXB1/
FKH5 
27 5237 
30 Forkhead box H1 FOXH1/ 
FAST1 
0 - 
31 Hypocretin (orexin) 
neuropeptide precursor 
HCRT 0 - 
32 Cholecystokinin 
preproprotein 
CCK 0 - 
33 Neuropeptide Y NPY 0 - 
34 Agouti related protein AGRP 0 - 
35 Thyrotropin-releasing 
hormone 
TRH 0 - 
36 Somatostatin SST 0 - 
37 Cocaine and amphetamine 
regulated transcript 
CART 0 - 
38 Pro-melanin-concentrating 
hormone 






40 Proenkephalin PENK 0 - 
41 Nerve growth factor (beta 
polypeptide) 
NGFB 0 - 
42 Brain-derived neurotrophic 
factor 
BDNF 10 1302 
43 Insulin-like growth factor 1 IGF1 4 506 
44 Vasoactive intestinal peptide VIP 0 - 
45 Cryptochrome 1 (photolyase-
like) 
CRY1 0 - 
46 Cryptochrome 2 (photolyase-
like) 
CRY2 0 - 





48 Noggin NOG 0 - 
49 Chordin CHRD 0 - 
50 TGFB-induced factor 
homeobox 1 
TGIF 0 - 
 Total 206 29890 
 
 
Of the 50 genes analyzed, about a third of the genes (17 of 50 genes) contained 4 or more 
conserved elements in their noncoding sequences, with 7 genes containing more than 10 
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CNEs per locus. On the other hand, no CNEs were detected in about 40% of the genes 
(21 of 50 genes). To ascertain the types of genes associated with CNEs, I identified the 
gene ontology (GO) terms (http://www.geneontology.org/) associated with the 50 genes. 
The GO terms associated with genes containing different spectrum of CNEs are shown in 
Table 2. CNEs tend to be associated with genes that encode transcription factors and 
those that play a role in development. This is consistent with the whole-genome 
comparisons of human and fugu in which a significant proportion of CNEs identified 
were found to cluster around transcription factor and developmental genes (Bejerano et 
al., 2004; Woolfe et al., 2005). However, about a quarter of the genes which lack CNEs 
(5 out of 18 genes) were found to encode transcription factors or developmental genes. 
Thus it seems that not all types of transcription factor and developmental genes contain 
evolutionarily constrained regulatory elements. It is possible that these genes are either 
regulated differently in mammals and fish, or regulated similarly but their regulatory 
elements are divergent, or that these genes may express ubiquitously and as such do not 
require tissue-specific enhancers. Indeed, verification of their expression patterns as 
indicated in the GNF SymAtlas (http://symatlas.gnf.org/SymAtlas/), showed that all these 
five transcription-factor genes are expressed in a wide range of tissues. These tissues may 
therefore lack tissue-specific enhancers. My analysis of CNEs also showed that some 
non-transcription factor genes, such as genes encoding hormones and metabolic 
regulators (lipid catabolism), contain 3 or more CNEs. The regulatory network of these 
non-transcription factor genes seems to be highly conserved during evolution. This 




Table 2: Number of CNEs identified and the functional categories of genes. TF: 
transcription factor; MCH: melanin-concentrating hormone 
 
No of CNEs No of genes Gene Ontology terms 
>10 6 DNA binding; TF activity; regulation of transcription; 
development; nucleic acid binding; Zn ion binding 
1 Growth factor activity 
4-10 9 DNA binding; TF activity; regulation of transcription; 
development; nucleic acid binding; Zn ion binding 
1 Hormone activity 
3 3 DNA binding; TF activity; regulation of transcription; 
development 
1 Phospholipase A2 activity; calcium ion binding; lipid 
catabolism 
2 2 DNA binding; TF activity; regulation of transcription; 
nucleic acid binding; Zn ion binding 
1 6 DNA binding; TF activity; regulation of transcription; 
development; Zn ion binding 
0 5  DNA binding; TF activity; regulation of transcription; 
development 
5 Signal transducer activity; signal transduction; hormone-
mediated signaling; neuropeptide signaling pathway 
6  Hormone activity; MCH activity 
3  Growth factor activity; negative regulation of cell 
differentiation 
2 DNA photolyase activity; DNA repair 
 
 
Of the 206 CNEs identified in my analysis of 50 human genes, only 22 overlap with the 
CNEs identified in whole-genome comparisons of human and fugu (Woolfe et al., 2005). 
Thus my analysis has identified a large number of novel CNEs associated with forebrain 
genes in the human genome. 
 
3.4 Summary 
By analyzing the noncoding regions of 50 human forebrain genes, I was able to identify 
206 CNEs associated with 29 genes. These CNEs include a large number of novel CNEs 
that were not identified in previous comparisons of human and fish genomes. These 
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CNEs are likely to be functional noncoding sequences that are under selective pressure in 
human and fish genomes. In order to confirm that they are indeed transcriptional 
enhancers, I proceeded to systematically test the functions of some selected CNEs in 
transgenic mouse using a β-galactosidase reporter gene. For this purpose, I selected two 
transcription factor genes that function at different levels in the hierarchy of the gene 
regulatory network of forebrain development, and assayed the functions of 13 CNE 
regions associated with them at different stages of mouse embryo development. The two 
genes I selected are Six3 and Foxb1. Six3 is a master regulator essential for the early 
specification and development of the forebrain and eye. Foxb1 is a transcription factor 
required for the normal development of the diencephalon and mammary glands. In 
addition, I also decided to analyze the regulatory region of a gene that shows tissue-
specific expression but does not contain any CNE. The gene I selected was orexin (ORX), 
which codes for a neuropeptide hormone and functions as an effector downstream in the 
gene-regulatory network. The objective of this experiment is to determine how in the 
absence of a conserved regulatory element the tissues-specific expression of a gene is 
achieved. To ascertain this I first generated transgenic mice carrying regulatory 
sequences of fugu to determine if the fugu ORX gene is regulated in the same way as the 
mouse gene, and then I localized the regulatory region in the fugu gene by progressive 
deletion of its regulatory region. I will present the results of the analysis of the three 

















       Chapter 4 
 
Results 





The transcription factor Six3 is a member of the Six/sine oculis family of homeobox 
transcription factors, which also contain a SIX domain that binds to cofactors and 
participate in transcriptional activation (Lopez-Rios et al., 2003). The first vertebrate Six3 
gene was cloned and characterized in mouse (Oliver et al., 1995). In early embryonic 
development Six3 expression is restricted to the anterior neural plate, including regions 
that will later give rise to ectodermal and neural derivatives, suggesting that this gene is 
involved in establishing positional information at the anterior boundary of the developing 
mouse embryo (Oliver et al., 1995). Vertebrate Six3 gene has been subsequently isolated 
from chicken (Bovolenta et al., 1998), medaka (Loosli et al., 1998), zebrafish (Seo et al., 
1998), Xenopus laevis (Zhou et al., 2000), and human (Granadino et al., 1999). Sequence 
comparisons show extensive identity within the homeodomain and the SIX domain. In all 
vertebrates, Six3 is expressed from the neurala stage first in the anteriormost neural plate 
and then in its derivatives: the developing eyes and olfactory placodes, the hypothalamic 
pituitary regions and the ventral telencephalon. 
 
A number of studies that manipulated Six3 expression in fish and mouse have 
demonstrated its essential role in eye and forebrain development (Kobayashi et al., 1998; 
Lagutin et al., 2001; Loosli et al., 1999). Targeted inactivation of Six3 in medaka fish 
embryos by morpholino knock-down resulted in the lack of forebrain and eye 
development (Carl et al., 2002). Similarly Six3-null mice displayed anterior truncation of 
the forebrain and died at birth, lacking most of the head structures anterior to the 
midbrain including the eyes (Lagutin et al., 2003). Conditional deletion of mouse Six3 in 
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the presumptive lens ectoderm (PLE) disrupted lens formation, and showed that Six3 is 
essential in the PLE to activate Pax6 expression for lens induction (Liu et al., 2006). In 
addition, mutations in Six3 have been found in humans affected by holoprosencephaly 
(Wallis et al., 1999), which is a severe malformation of the brain that involves separation 
of the central nervous system into left and right halves. Many gene loci have been 
implicated in the aetiology of holoprosencephaly including Six3. Mutational analysis in 
holoprosencephaly patients has identified four different mutations in the homeodomain of 
Six3 that are predicted to interfere with the transcriptional activation of Six3 (Wallis et al., 
1999).  
 
How the activity of Six3 with multiple functions and several expression domains during 
embryo development is regulated remains to be fully elucidated. To identify cis-
regulatory elements that mediate expression of human Six3 to different domains during 
development, I chose to identify conserved noncoding elements in the Six3 loci of 
human, mouse and fugu and validate their function in transgenic mice during embryonic 
development.  
 
4.2 Six3 loci in human, mouse and fugu, and identification of CNEs 
Identification of Six3 ortholog in fugu using Ensembl Biomart annotation and 
INPARANOID showed that fugu contains a single ortholog unlike duplicate copies of 
Six3 discovered in zebrafish (Seo et al., 1998) and medaka (Conte and Bovolenta, 2007). 
The genomic sequences for the human, mouse and fugu Six3 genes were retrieved from 
Ensembl (see Materials and methods).  Scanning of the genes located upstream and 
 63 
downstream of Six3 in the human, mouse and fugu genome assemblies indicated that the 
synteny of the genes in this locus is highly conserved in the three genomes (Figure 3). 
The protein sequence of Six3 is encoded by a single exon in human, mouse and fugu. The 
5’ and 3’ flanking sequences of Six3 span 580 kb and 50 kb in human and 420 kb and 50 
kb in mouse, respectively. The flanking sequences of Six3 is unusually large (76 kb and 
15 kb; Figure 3) in fugu in which the overall gene density is only one gene/~18 kb and 
the intergenic regions are generally short (http://www.fugu-sg.org/). The vast noncoding 
sequences flanking the Six3 gene indeed poses a challenge for identifying cis-regulatory 
elements regulating the expression of this gene.  
 
 
Figure 3: Six3 loci of human, mouse and fugu. Arrows represent genes and the direction 




The orthologous genomic sequences comprising the entire 5’ and 3’ flanking regions of 
the human, mouse and fugu Six3 genes were aligned using the global alignment algorithm 
 64 
MLAGAN (http://genome.lbl.gov/vista/lagan/) using fugu as the reference sequence, and 
CNEs (>60% identity and larger than 50 bp) were predicted using VISTA. A total of 14 
mammal-fugu CNEs were predicted in the Six3 loci (Figure 4). While one of these CNEs 
(CNE14) is located in the 3’-flanking region, CNE13 (224 bp) is located just 200 bp 
upstream of the transcription initiation site and thus likely to overlap with the upstream 
basal promoter of Six3. The remaining CNEs (CNE1 to CNE12) are located in the 5’-
flanking region. In the human genome, these CNEs are spread over a region of 163 kb 
with the most upstream CNE located 140 kb from the transcription start site. For the 
purpose of testing these CNEs in transgenic mice, CNEs located in clusters were grouped 
together and their combined sequences were amplified by PCR while the rest were 
amplified as individual CNEs (Figure 4). One drawback of the clustering is that the 
expression patterns of the cluster reflect the combined expression pattern of the CNEs 
clustered and as such, the contribution of individual CNEs is not clear. The details of the 
CNEs tested are given in Table 3. In all, eight noncoding sequences were tested in 
transgenic mice. I first tested the function of the basal promoter (that includes CNE13) 
alone by cloning it upstream of a β-galactosidase reporter, and then tested the functions 
of other CNEs by cloning each of them upstream of the basal promoter. Expression of 
lacZ was assayed by in situ hybridization using a lacZ-specific riboprobe on transgenic 
embryos or embryo sections at various developmental stages. The resulting expression 
profiles from each construct shared by at least three transgenic embryos for each 









   CNE1   CNE2/3/4   CNE5/6/7  CNE8/9    CNE10/11            CNE12          CNE13 CNE14 
 
Figure 4: Conserved noncoding elements in the Six3 locus. VISTA plot of the 
MLAGAN alignment of the fugu, mouse and human Six3 loci is shown. Fugu was used 
as the base sequence. CNEs were predicted as noncoding sequences that are ≥60% 
identity across 50 bp or longer. Peaks represent conserved sequences; coding sequences 
are shaded blue and non-coding sequences (CNEs) are shaded pink. The arrow indicates 
the direction of transcription of Six3. The 14 CNEs are highlighted by red rectangle 
boxes. CNE13 likely overlaps with the promoter sequence. The pink peaks outside the 
red boxes overlapped with NCBI EST sequences and hence were not counted as CNEs. 









% identity Approximate 
distance 





CNE1 1 80 76.3 -140 kb 220 
CNE2/3/4 3 203 68.4 -138 kb 480 
CNE5/6/7 3 496 71.3 -103 kb 740 
CNE8/9 2 473 75.1 -100 kb 610 
CNE10/11 2 149 79.5 -63 kb 445 
CNE12 1 88 85.2 -42 kb 290 
CNE13  1 224 75.0 -200 bp 860 
CNE14 1 78 66.7 +20 kb 380 
 
Table 3: Six3 CNEs tested in transgenic mice. The length, percent identity and location 
of the CNEs are shown. The actual size of the mouse noncoding sequence amplified and 










In the course of my work, a similar comparative genomics approach was used to identify 
the regulatory elements of Six3 gene in the teleost fish, medaka (Conte and Bovolenta, 
2007). Like zebrafish, medaka contains duplicate copies of Six3. Conte and Bovolenta 
aligned ~20 kb sequence upstream of translational start site of one of the medaka Six3 
genes (olSix3.2) with corresponding sequences from the single copy Six3 in fugu and 
Tetraodon, and the duplicated Six3 in zebrafish, and identified 10 blocks of conserved 
noncoding sequences (>75% identity over 100 bp) contained within the first 4.5 kb 
genomic region flanking the translation start site. Functional assay of these conserved 
blocks of noncoding sequences (designated blocks A to L) in transgenic medaka revealed 
that they include two enhancer modules, D and I, that recapitulate expression of medaka 
olSix3.2 at early (stages 16-21) and late (stages 24-40) stages of brain development, 
respectively, and two ‘silencers’ and two ‘silencer blockers’ that restrict the spatial 
expression of the two enhancers. In addition, a combination of five different modules 
(spread between modules D and H) was found to be responsible for the expression of 
olSix3.2 in the lens ectoderm and in the differentiating retina during stages 22-23. Thus, 
the conserved modules within the first 4.5 kb genomic sequence were found to be 
adequate for driving expression of olSix3.2 during early and late stages of brain 
development. Interestingly, only one of these conserved noncoding sequence blocks 
(block L) overlapped with a fugu-mammal CNE (CNE13) identified by me. This block 
did not exhibit any function when assayed in transgenic medaka (Conte and Bovolenta, 
2007). Although another medaka conserved sequence (block G) overlapped with a 
conserved noncoding sequence in my MLAGAN alignment, it was excluded from my set 
of CNEs as it showed high similarity to mouse Six3 opposite strand transcript sequence 
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from the NCBI EST database. It should be noted that Conte and Bovolenta were able to 
identify rearranged fragments of medaka blocks H and I in human and Xenopus Six3 loci 
and these rearranged sequences were able to recapitulate part of the combined expression 
patterns of H and I in transgenic medaka.  Since these rearranged conserved fragments 
fall below the conservation criteria used for identifying fugu-mammal CNEs, they were 
not predicted as CNEs by VISTA in my study. Thus, most of the conserved noncoding 
blocks of medaka sequences identified by Conte and Bovolenta (2007) appear to be 
specific to teleost fishes. In contrast, the CNEs identified by me are evolutionarily 
constrained sequences that are conserved all the way from teleost fishes to mammals, and 
are likely to have functions in teleost fishes and mammals.  
 
4.3 Expression pattern of mouse Six3  
The expression pattern of Six3 in the mouse embryos during the early stages of 
development (embryonic days E9.5 to E11.5) and the late stages of development 
(embryonic days E13.5 to E15.5) has been previously investigated (Oliver et al., 1995). 
However, for the sake of comparison of the expression pattern of the mouse Six3 gene 
with the expression pattern of the reporter gene driven by mouse Six3 CNEs, I 
determined the expression pattern of the Six3 gene in the FVB/N mouse strain used for 
testing the CNEs. The expression in the early stages of development (E9.5-E11.5) was 
analyzed by a whole-mount in situ hybridization using an antisense RNA probe that binds 
specifically to a 380 bp fragment of the mouse Six3 coding region whereas expression 
during the late stages of development was investigated by in situ hybridization of sagittal 
(E13.5) or coronal (E15.5) sections of the mouse embryos using the same probe. At E9.5, 
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the expression of Six3 was detected in the ventral forebrain and optic vesicles, with some 
signal observed in the midbrain tegmentum (Figure 5A). By E10.5, the expression was 
localized predominantly in the forebrain, midbrain tegmentum and optic vesicle (Figure 
5B). At E11.5, the expression persisted in the differentiated telencephalon and 
diencephalon of the forebrain, and the optic vesicle with some expression in the midbrain 
tegmentum. Low levels of expression were also detected in the olfactory placodes (Figure 
5C). At later stages of development (E13.5), Six3 labeling was clearly seen in the ventral 
thalamus, hypothalamus and Rathke’s pouch (Figure 5D) which are all derived from the 
diencephalon; as well as in the olfactory epithelium of the nasal cavities (Figure 5E) and 
the neural retina (localized in the inner neuroblastic layer) and lens of the differentiated 
eye (Figure 5F). Six3 mRNA was also seen in the telencephalon, specifically in the 
striatum (Figure 5G). At E15.5, expression remained in the thalamus and telencephalon 
(Figure 5H) and in the hypothalamus and eye (Figure 5I). These expression patterns are 
in general agreement with the expression patterns of mouse Six3 previously reported by 
Oliver et al. (1995).  
 
      
A B C 
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Figure 5: Expression patterns of Six3 in the developing mouse embryo. (A-C) Whole 
mount in situ hybridization of wild type embryos showing expression of mouse Six3. At 
E9.5, mRNA accumulation was seen in the forebrain, midbrain tegmentum and optic 





At E11.5, expression persisted in the differentiated telencephalon and diencephalon of the 
forebrain, the optic vesicle and weakly in the olfactory placodes (C). (D-I) In situ 
hybridization of cryosections of the head of wild-type embryos with a 380 bp fragment of 
the mouse Six3 exon as a probe at E13.5 (D-G) and E15.5 (H-I) show that mouse Six3 
expression is detected at E13.5 in the thalamus, hypothalamus and Rathke’s pouch of the 
diencephalon (D); olfactory epithelium (E); neural retina and lens of the eye (F); and 
striatum of the telencephalon (G) and at E15.5, expression was maintained in the 
telencephalon and thalamus (H); and hypothalamus and neural retina and lens of the 
differentiated eye (I). D: diencephalon; FB: forebrain; HT: hypothalamus; L: lens; MB: 
midbrain; NR: neural retina; OE: olfactory epithelium; OP: olfactory placodes; OV: optic 
vesicle; RC: Rathke’s pouch; S: striatum; T: telencephalon; Th: thalamus. Scale bar = 
100 µm unless otherwise indicated. 
 
 
4.4 Functional assay of Six3 CNEs 
4.4.1 Basal promoter region (includes CNE13) of mouse Six3 is sufficient to 
recapitulate most aspects of expression in the forebrain and eye during early and 
late stages of development 
I first tested the function of the promoter region alone to determine its contribution to the 
expression pattern of mouse Six3 gene. A 860 bp fragment of the mouse Six3 promoter 
region, spanning from  -450 bp to +410 bp in relation to the transcriptional start site, was 
amplified and cloned upstream of a β-galactosidase reporter gene. This region of the 
promoter includes the highly conserved CNE13 which spans from -200 to +24 bp. This 
construct did not show expression of the reporter gene in E9.5 embryos. However at 
E10.5, it showed consistent expression in the forebrain and optic vesicle (Figure 6A). 
This expression pattern persisted at E11.5 (Figure 6B). This restricted expression profile 
is similar that of the endogenous mouse Six3 expression at E10.5 and E11.5 stages and 
indicates that the 860-bp promoter region is capable of recapitulating the expression 
pattern of mouse Six3 at stages E10.5 and E11.5.  At later stages of E13.5 and E15.5, 
expression of the transgene was detected in the striatum of the telencephalon (Figure 6C 
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and 6G); the hypothalamus and thalamus of the diencephalon (Figure 6D and 6H); the 
neural retina where the signal was localized to the inner neuroblastic layer, the lens of the 
eye (Figure 5E and 5I); the olfactory epithelium of the nasal cavity (Figure 6F); as well as 
the midbrain tegmentum (Figure 6J). In addition, ectopic expression was observed in the 
hindbrain (Figure 6J). Overall, this construct directed expression in all the domains in 
which mouse Six3 shows expression except in the Rathke’s pouch (Figure 6D). These 
results indicate that the 860-bp promoter region is capable of reproducing expression of 
Six3 in almost all domains in the differentiated forebrain during late embryo 
development. Thus the 860-bp promoter region alone seems to be capable of reproducing 
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Figure 6: A 860-bp promoter region of mouse Six3 directs expression of lacZ mRNA 
to the forebrain and eye during embryonic development. (A-B) Whole mount in situ 
hybridization of transgenic embryos show that the 860-bp promoter region directs 
expression of reporter gene in the forebrain and optic vesicle at E10.5 (A) and at E11.5 
(B). (C-J) In situ hybridization of cryosections of the head of transgenic embryos at E13.5 
(C-F) and E15.5 (G-J) show that the 860-bp promoter region directs lacZ expression to 
the telencephalon (C, G); the hypothalamus and thalamus of the diencephalon (D, H); the 
neural retina and lens of the differentiated eye (E, I); and the olfactory epithelium of the 
nose (F). Ectopic transgene expression was also detected in the hindbrain (J). D: 
diencephalon; E: eye; FB: forebrain; HT: hypothalamus; L: lens; MB: midbrain; NR: 
neural retina; OE: olfactory epithelium; OV: optic vesicle; P: Pons; S: striatum; T: 





4.4.2 Expression patterns directed by CNE1, CNE2/3/4 and CNE5/6/7  
CNE1 spans 80 bp and was amplified as a 220 bp fragment and cloned upstream of the 
mouse Six3 promoter construct. CNE2/3/4 was made up of three conserved fragments 
spanning a total of 203 bp and were amplified together as a 480 bp fragment and cloned 
upstream of the mouse Six3 promoter. CNE5/6/7 comprised 3 conserved sequences 
spanning almost 500 bp of genomic sequence, and was cloned as a 740 bp fragment 
upstream of the promoter. Expression of these transgenes was then individually assayed 
at the same time points using lacZ RNA probes.  
 
At E9.5 no transgene expression was detected for CNE1. However at E10.5, lacZ mRNA 
expression directed by CNE1 and the promoter was found to express in the forebrain 
(Figure 7A), with similar intensity to the endogenous gene expression. Expression 
however was more intense in the midbrain. In addition, ectopic expression was found in 
the hindbrain (Compare Figure 7A with Figure 5B), and these domains of expression 
intensified at E11.5 (Figure 7B). No expression was detected in the optic vesicle at these 
stages. Therefore the effect of CNE1 on the promoter was to inhibit optic vesicle 
expression at E10.5 and E11.5. Similarly for CNE2/3/4, no expression was detected in 
transgenic embryos at E9.5. At E10.5, expression of the transgene was seen in the 
forebrain and the optic vesicle, as was observed with the “promoter alone” construct 
(Figure 7C). However at E11.5, expression in the optic vesicle was abolished while that 
in the forebrain intensified (Figure 7D). This showed CNE2/3/4 had no effect on the 
promoter at E10.5 and acted only at E11.5 to repress expression in the optic vesicle. For 
CNE5/6/7, there was no signal detected at E9.5. The expression at E10.5 was similar to 
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that of the promoter alone, where expression was detected in the forebrain and optic 
vesicle. However at E11.5, expression was abolished in the optic vesicle, and ectopic 
expression was detected in the midbrain and hindbrain (Figure 7E), which was also 
observed for CNE1 at that particular stage of development. Therefore the effect of 
CNE5/6/7 on the promoter was similar to that of CNE1 in silencing optic vesicle 
expression but it occurred only at a single time point of E11.5. 
 
At later stages of E13.5 and E15.5, all three constructs (CNE1, CNE2/3/4 and CNE5/6/7) 
directed expression to the differentiated telencephalon; hypothalamus and thalamus; 
neural retina and lens; olfactory epithelium; midbrain tegmentum; as well as ectopically 
in the hindbrain, indicating CNE1 and,CNE2/3/4 had no observable phenotypic effect on 
the promoter at these stages. However it was noticeable that by E15.5, lens expression in 
CNE5/6/7 positive embryos (Figure 7F) had diminished considerably as compared to the 
expression in the lens driven by the basal promoter construct (Figure 6I). CNE1 and 
CNE2/3/4 therefore had no effect on the promoter while CNE5/6/7 seemed to function as 
a silencer of lens expression during the later stages of embryonic development. 
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Figure 7: Expression patterns directed by CNE1, CNE2/3/4 and CNE5/6/7. (A-E) 
Whole mount in situ hybridization stained transgenic embryos that show lacZ mRNA 
labeling. CNE1 drove lacZ mRNA expression to the forebrain, midbrain and ectopically 
in the hindbrain, and inhibited optic vesicle expression at E10.5 (A) and E11.5 (B). 
CNE2/3/4 had no effect on the promoter-driven expression at E10.5 (C), but at E11.5 it 
inhibited expression in the eye while maintaining expression in the forebrain (D). 
CNE5/6/7 directed expression in the same way as CNE1 but only at the particular stage 
of E11.5 (E). (F) Coronal section of the head of a CNE5/6/7 positive embryo showed 
inhibition of lens expression at E15.5. D: diencephalon; FB: forebrain; HB: hindbrain; L: 
lens; .MB: midbrain; NR: neural retina; OV: optic vesicle; T: telencephalon. Scale bar = 
100 µm unless otherwise indicated. 
 
 
4.4.3 Expression patterns directed by CNE8/9 and CNE12  
CNE8/9 spanning 473 bp of genomic DNA had one of the longest sequences conserved 
between fugu and mammals. This was amplified as a 610 bp fragment and cloned 
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embryos. Expression of the transgene was detected as early as E9.5 in the forebrain and 
optic vesicle, similar to the endogenous gene expression (Figure 8A). However there was 
more intense expression in the midbrain and ectopic expression in the hindbrain as well 
(Figure 8A) and expression at these domains intensified at E10.5 (Figure 8B). However 
at E11.5, optic vesicle expression was abolished while expression remained in the 
forebrain, midbrain and ectopically in the hindbrain (Figure 8C). This suggested CNE8/9 
acted as both an enhancer and a silencer of the basal promoter: it activated forebrain and 
optic vesicle expression at E9.5 to recapitulate the endogenous gene expression, and it 
silenced eye expression at E11.5. At later stages of development (E13.5-E15.5), eye 
expression was restored while forebrain and midbrain expression were maintained 
together with ectopic expression in the hindbrain region, similar to the expression profile 
observed with that of the basal promoter construct. However there were two important 
differences. Firstly, CNE8/9 also directed expression to the Rathke’s pouch (Figure 8D) 
that was not specified by the promoter alone, and secondly retinal expression at E15.5 
was severely diminished (Figure 8E) as compared to that directed by the promoter alone. 
This suggested that CNE8/9 also acted as a Rathke’s pouch enhancer and a retina silencer 
in the later stages of embryo development. 
 
CNE12 was much smaller in size, comprising of a single conserved sequence of 88 bp 
that was cloned as a 290 bp fragment upstream of the mouse Six3 promoter. Its enhancer 
potential was assayed in transgenic mice embryos. CNE12 together with the basal 
promoter acted early at E9.5 to drive lacZ mRNA expression to the forebrain, midbrain 
and optic vesicle (Figure 8F). This expression persisted at relatively high levels at E10.5 
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(Figure 8G) and E11.5 (Figure 8H). In addition, there was strong ectopic expression in 
the hindbrain and neural tube during these stages (Figure 8I and 8J). Expression in the 
differentiated forebrain, midbrain and ectopically in the hindbrain persisted through to 
E15.5, and included the Rathke’s pouch (Figure 8K). However at E13.5, retinal 
expression was abolished (Figure 8L) while at E15.5, retinal expression was restored but 
scattered throughout the retina and was not localized to the inner neuroblastic layer like 
with the endogenous gene expression, and lens expression was abolished (Figure 8M). 
Therefore CNE12 was similar to CNE8/9 in being an enhancer that directed expression to 
the forebrain, midbrain and optic vesicle from E9.5, as well as an enhancer to direct 
expression in the Rathke’s pouch at later stages of development. However it also 
functioned as a silencer of expression in both the retina and lens at E13.5 and E15.5 
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Figure 8: Expression patterns directed by CNE8/9 and CNE12. (A-C) Whole mount in 
situ hybridization stained E9.5 (A), E10.5 (B) and E11.5(C) CNE8/9 positive embryos 
showed lacZ mRNA labeling in the forebrain, midbrain, optic vesicle (A, B only) and 
ectopically in the hindbrain. (D) Sagittal section of the head of an e13.5 CNE8/9 positive 
embryo showed lacZ mRNA labeling in the Rathke’s pouch. (E) Coronal section of the 
head of an E15.5 CNE8/9 transgenic embryo showed diminished labeling in the neural 
retina. (F-J) Whole-mount in situ hybridization stained E9.5 (F), E10.5 (G, H) and E11.5 
(I, J) CNE12 positive embryos showed lacZ mRNA labeling in the forebrain, midbrain, 
optic vesicle and ectopically in the hindbrain and neural tube. (K) Sagittal section of the 
head of an e13.5 CNE12 positive embryo showed lacZ mRNA labeling in the Rathke’s 
pouch. (L, M) Coronal section of the head of CNE12 positive embryos showed 
diminished labeling in the neural retina at E13.5 (L) and abolished lens expression at 
E15.5 (M). D: diencephalon; FB: forebrain; HB: hindbrain; HT: hypothalamus; L: lens; 
MB: midbrain; NR: neural retina; NT: neural tube; OV: optic vesicle; RC: Rathke’s 
pouch; T: telencephalon; Th: thalamus. Scale bar = 100 µm unless otherwise indicated. 
 
 





4.4.4 CNE10/11 silences the mouse Six3 promoter at all developmental stages 
CNE10/11 consisted of two conserved peaks spanning 150 bp that were amplified as a 
single fragment of size 445 bp and cloned upstream of the mouse Six3 promoter. Mouse 
embryos containing the CNE5-promoter construct were harvested at different time points 
as before, and lacZ mRNA was detected using whole-mount in situ hybridization or 
mouse embryo heads were sectioned prior to hybridization with lacZ RNA probes. In 
total I analyzed 33 transgenics including more than 3 transgenic embryos per time point, 
and remarkably no lacZ mRNA labeling was detected in any tissue at any of the time 
points. Therefore CNE10/11 seemed to function as a complete silencer that repressed 
expression by the mouse Six3 promoter in all tissues and at all stages of embryonic 
development. 
 
4.4.5 Expression pattern directed by CNE14 
CNE14 was the least conserved sequence spanning 78 bp and amplified as a 340 bp 
fragment. At E9.5, CNE14 directed lacZ mRNA expression to the early forebrain and 
optic vesicle of the mouse embryo (Figure 9A), consistent with the endogenous gene 
expression. CNE14 then directed ectopic lacZ mRNA expression to the hindbrain and 
inhibited expression in the optic vesicle at E10.5 (Figure 9B). At E11.5, CNE14 restricted 
expression to only the forebrain (Figure 9C). Therefore the effects of CNE14 on the 
promoter were the most dynamic. It acted as an enhancer to direct expression to the 
forebrain and optic vesicle at E9.5. In addition it silenced optic vesicle expression at 
E10.5 and E11.5 as well as mediated ectopic expression to the hindbrain at E10.5.  
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Figure 9: Expression pattern directed by CNE14 at E9.5-E11.5.  (A-C) Whole mount 
in situ hybridization stained E9.5 (A), E10.5 (B) and E11.5(C) CNE14 positive embryos 
showedCNE14 enhanced expression of lacZ mRNA in the forebrain and optic vesicle at 
E9.5 (A). At E10.5, CNE14 inhibited optic vesicle expression and activated ectopic 
expression in the hindbrain (B). At E11.5, ectopic expression was abolished but 
inhibition of expression in the optic vesicle persisted (C). FB: forebrain; HB: hindbrain; 
MB: midbrain; OV: optic vesicle.  
 
 
4.4.6 Summary of the regulatory potential of mouse Six3 CNEs 
The CNEs I analyzed from the mouse Six3 locus all functioned as tissue-specific 
enhancers and / or silencers in transgenic mouse embryos. CNE13 and its flanking 
sequences likely represent the basal promoter that directs expression to almost all 
domains of the endogenous mouse Six3 expression in both the early and late stages of 
embryo development, while the other CNEs work in concert with the basal promoter to 
silence or enhance particular domains of expression at particular stages of development. 
Table 4 provides a summary of the effect of each CNE on the expression pattern driven 
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Enhancer from E10.5 Enhancer of T, 
HT, Th, OE, 
NR, L in the 
differentiated 
FB and eye 
13-P  
+1 







  Silencer at E11.5  
13-P 
+5/6/7 
 Ectopic expression at 
E11.5 only 






at E9.5  
Ectopic expression at 
E9.5-e11.5 




at E13.5  
13-P 
+10/11 




at E9.5  
Ectopic expression at 
E9.5-E11.5 including 
neural tube 
Silencer at E13.5 









Ectopic expression at 
E10.5 only 





Table 4: Enhancer function of mouse Six3 CNEs across different developmental 
stages and in different tissues. CNE13 is part of the basal promoter tested. Other CNEs 
were cloned upstream of the basal promoter construct (CNE13-P) and expression pattern 
was assayed using in situ hybridization that detected lacZ mRNA labeling and compared 
with that driven by the basal promoter alone. The differences in the expression pattern 
conferred by each CNE are then tabulated. FB: forebrain; HB: hindbrain; HT: 





Six3 is an important regulator of vertebrate forebrain development and defining the 
precise gene regulatory network that controls its spatiotemporal expression would help in 
elucidating the mechanisms by which it regulates forebrain and eye development. This 
study has allowed a better understanding of the transcriptional mechanisms responsible 
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for regulating Six3 expression in a tissue and developmental-stage specific manner. 
Firstly, CNE13 together with the flanking sequences representing the basal promoter was 
able to specify forebrain and optic vesicle expression from E10.5, maintain it at E11.5, 
and by later stages (E13.5-E15.5) direct expression to the differentiated forebrain 
(telencephalon, striatum, hypothalamus and thalamus), midbrain tegmentum, eye (neural 
retina and lens), olfactory epithelium. This meant the basal promoter could recapitulate 
the majority of the endogenous mouse Six3 expression domains. However, it is not clear 
if this expression pattern is due to the CNE13 sequence or the sequences flanking it in the 
basal promoter construct tested or a combination of both, although the high level of 
conservation of CNE13 suggests that it is most likely playing a role in the expression 
patterns observed with this construct. In the early developmental stages of E10.5-E11.5, 
the basal promoter alone was sufficient to reproduce endogenous gene expression levels 
in the forebrain and optic vesicles. However in the later stages of development, the 
promoter was insufficient to direct expression to Rathke’s pouch, and it did not down-
regulate expression in the hindbrain, as according to the endogenous gene expression 
level. A silencer located in this locus is likely to be involved in suppressing the 
expression of the basal promoter in the hindbrain during development to ensure the 
correct expression of Six3 during development. 
 
Secondly the remaining CNEs in the Six3 locus acted as enhancers and/or silencers with 
overlapping functions. Having determined the function of the basal promoter in directing 
transgene expression at several time points, the function of individual enhancers that 
were ‘added on’ to the basal promoter construct can be deduced by a comparison of 
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expression patterns resulting from the effect of individual CNEs on the basal promoter, 
with that observed due solely to the action of the basal promoter. I found at least three 
early enhancers (CNE8/9, CNE12 and CNE14) that directed expression to the forebrain 
and optic vesicle at E9.5, reproducing endogenous gene expression at that stage and this 
complemented the action of the promoter from E10.5. There were at least 5 enhancers 
that gave rise to ectopic expression in the hindbrain at levels greater than that seen for the 
endogenous gene expression and at earlier stages of development compared to the basal 
promoter (see Figures 7B, 7E, 8C, 8H, 8J and 9B). This ‘leaky’ expression was present 
either early from E9.5 (CNE8/9 and CNE12) or only at a particular time point (CNE1, 
CNE5/6/7 and CNE14). It would appear the activity of some of the identified regulatory 
elements was not properly turned off when these elements were studied outside their 
normal genomic context. In the genomic context of the Six3 locus, these enhancers would 
have had to be modulated or repressed by other cis- and/or trans-acting agents, so as not 
to give rise to ‘leaky’ expression levels in the hindbrain. Strangely, many of these 
enhancers functioned simultaneously as silencers of expression in the optic vesicle and/or 
in the differentiated retina or lens, either over a few developmental stages (CNE1, 
CNE8/9 and CNE12) or at a particular time point (CNE2/3/4, CNE5/6/7 and CNE14). 
CNE5/6/7, CNE8/9 and CNE12 were the only three enhancers that helped to modulate 
the action of the endogenous promoter at later developmental stages, by firstly specifying 
expression in Rathke’s pouch (CNE8/9 and CNE12) as well as inhibiting expression in 
the differentiated retina (CNE8/9 and CNE12) and lens (CNE5/6/7 and CNE12). Being 
one of the primary domains of Six3 expression, it was surprising to find the presence of 
many silencer elements of eye expression. It is likely that in the context of the whole 
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locus, these repressors worked in combination to modulate the level of Six3 expression 
and were required to help maintain a physiologically appropriate dosage of Six3 
expression in the eye at all times.  
 
4.5.1 Comparison of results from Six3 regulation in medaka 
The cis-regulatory elements required for Six3 expression in medaka was found to be 
contained in a 4.5 kb genomic region upstream of the transcription start site of the 
medaka locus. They comprised two enhancer modules that directed early and late stages 
of brain development, two silencer modules and two silencer blocker modules, which 
together control Six3 expression in the lens and early retina of medaka (Conte and 
Bovolenta, 2007). Unfortunately the regulatory organization of the medaka Six3 locus 
was poorly conserved in vertebrates other than fishes. Out of the ten conserved blocks in 
fish, only two were highly conserved in human and mouse (Conte and Bovolenta, 2007), 
and were promptly detected in my MALGAN analysis. However, one of them (block G) 
matched the opposite strand transcript sequence of mouse Six3 in the NCBI EST database 
and was excluded from further analysis. Since this sequence in medaka (block G) 
functioned as a repressor of the late brain enhancer (block I) and is know to code for a 
transcript in mouse, it is possible that this sequence may code for a RNA gene that itself 
may be acting as a silencer.   The other conserved module (block L) overlaps with 
CNE13 in the Six3 basal promoter region, but unlike the basal promoter construct that 
directed reporter expression to almost all the mouse Six3-expressiong domains in both the 
early and late stages of development, it had no detectable function in directing reporter 
expression in transgenic medaka (Conte and Bovolenta, 2007). The difference in the 
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function could be due to the additional sequences flanking CNE13 in the basal promoter 
construct (CNE13-P). While the conserved module in medaka is only 224 bp, the basal 
promoter construct (860 bp long) tested by me contained about 240 bp region upstream 
and 400 bp downstream of the medaka conserved module. Another possibility is that the 
conserved module may be differentially utilized in medaka and mice, and that Six3 may 
be regulated differently in fishes and mammals. In medaka, each conserved module 
played a unique role as an enhancer or silencer or blocker in specific tissues with little 
overlap in function between the modules, while in mouse the basal promoter has taken on 
the function of primary enhancer in directing Six3 expression in almost all the required 
domains while the other conserved modules (CNEs) spread over a large region of 163 kb 
act in concert with the basal promoter to direct specific expression by modulating the 
promoter activity spatially or temporally and these enhancers show redundancy in their 
roles as secondary enhancers or silencers. I could not detect silencer-blocker activity as I 
tested the CNEs individually and only in conjunction with the promoter. The presence of 
CNE10/11 as a complete silencer however would suggest the need for silencer-blockers 
to neutralize this silencer when physiologically appropriate levels and correct domains of 
Six3 expression were required to be activated during the development of the forebrain 
and eye, and it is likely some of the CNEs I tested would have this silencer-blocker 
activity. This can be confirmed by testing CNEs in various combinations in transgenic 
mice. 
 
My study has shown that the regulation of Six3 in vertebrates is more complex than 
previously thought based on the identification of cis-regulatory elements in medaka. The 
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cis-regulatory elements are actually spread over much larger region than the proximal 4.5 
kb characterized by Conte and Bovolenta (2007) in medaka. Since the CNEs identified in 
my study are conserved in fugu, they are most likely to be present in medaka either in the 
sequences upstream of 4.5 kb proximal promoter sequences in olSix3.2 or in the 5’ and 3’ 
flanking regions of its duplicate copy olSix3.1 that remain to be characterized.  
Altogether the data I present here provide a more comprehensive picture of the regulatory 
code that governs Six3 expression during the development of the forebrain and eye in 
vertebrates. The regulatory code as revealed by the transgenic mice reporter gene assay  
is summarized in Figure 10. Firstly the basal promoter alone directs expression to the 
forebrain and optic vesicle in the early stages of development from E10.5; as well as to 
most of the Six3-expressing domains in the differentiated forebrain and the differentiated 
eye during the later stages of development (Figure 10A). This action of the promoter is 
dependent upon the silencer activity of CNE10/11. Secondly the other CNEs act to 
modulate the basal promoter. For example Six3 expression in the early forebrain at E9.5 
is mediated by at least three enhancers (CNE8/9, CNE12 and CNE14), two of which also 
mediate expression to Rathke’s pouch (Figure 10B). In addition most of the CNEs 
function as silencers of expression in the optic vesicle (Figure 10C) and in the retina and 
lens of the developing eye (Figure 10D) to help keep the expression of Six3 in the eye 
under strict control at all times. Thus, spatio-temporal code of Six3 regulation is provided 
by the combined use of at least 14 different modules, all conserved in fish and mammals, 
with distinct and overlapping roles as enhancers and silencers, but all working in concert 




Figure 10: Summary of the regulatory code that controls the expression of Six3 in 
mouse. (A) The basal promoter alone directs expression to the forebrain and optic vesicle 
in the early stages of development from E10.5; as well as to most of the Six3-expressing 
domains in the differentiated forebrain and the neural retina and lens of the differentiated 
eye during the later stages of development. This action of the promoter is dependent upon 
the silencer activity of CNE10/11 at all stages of development. (B) Six3 expression in the 
early forebrain at E9.5 is mediated by at least three enhancers (CNE8/9, CNE12 and 
CNE14), the former two of which also mediate expression to Rathke’s pouch. 
(C)Expression of Six3 in the optic vesicle during early development is mediated by at 
least one enhancer (CNE14) that activates expression at e9.5 and at least 5 silencers that 
repress expression at E10.5-E11.5. (D) Late eye expression of Six3 is in turn mediated by 
at least three silencers (CNE5/6/7, CNE8/9 and CNE12) that repress expression in either 
the lens or the neural retina at E13.5 or E15.5. FB: forebrain; L: lens; NR: neural retina; 
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The forkhead (Fox) gene family encodes more than one hundred transcription factors, 
each characterized by a “winged helix” configuration in their DNA-binding domain. 
These transcription factors play key roles in development, metabolism, aging, cancer and 
immunoregulation (Lehmann et al., 2003). Foxb1 was originally described under the 
names of HFH-5.1 and Fkh5 as an early expressing gene in the brain as well as in the 
neural plate and early mesoderm in primitive streak stage embryos (Ang et al., 1993; 
Kaestner et al., 1996). By midgestation in mouse, Foxb1 is restricted to specific 
populations of cells in the thalamus and hypothalamus, midbrain tegmentum, hindbrain 
and spinal cord; as well as in the mammary gland epithelium (Kloetzli et al., 2001; Wehr 
et al., 1997). Late in gestation and in newborn mice, the predominant region of 
expression for Foxb1 is the most caudal region of the hypothalamus, within the 
mammillary bodies, indicating its likely role in the growth and differentiation of a 
specific segment of the anterior forebrain (Labosky et al., 1997). Foxb1 has also been 
identified in zebrafish as playing an important role in the induction and patterning of the 
forebrain by specifying the posterior domain of the presumptive neuroectoderm in the 
developing embryo through its expression in the prospective diencephalon, 
mesencephalon and posterior hindbrain/spinal cord, before any morphological 
subdivision (Grinblat et al., 1998). The similarities in the expression patterns of Foxb1 in 
mouse and zebrafish suggest Foxb1 to be an important regulator of development and 
maintenance of these structures, and that its function is conserved among vertebrates. 
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To address its function, Foxb1 has been knocked out in a variety of ways, and the mutant 
phenotype in mice included increased perinatal mortality and growth retardation in the 
mutant embryos and pups that survive (Labosky et al., 1997); impaired differentiation of 
regions in the midbrain and hypothalamus that would compromise spatial memory 
formation (Wehr et al., 1997); impaired differentiation of neural progenitors in the spinal 
cord resulting in motor weakness (Dou et al., 1997); and incomplete lobuloalveolar 
development of the mammary glands resulting in a failure to generate the milk ejection 
reflex and an inability to lactate (Kloetzli et al., 2001). Therefore Foxb1 has multiple 
roles to play during embryogenesis and adult life, acting as an important regulator to fine-
tune development of the diencephalon, brainstem, spinal cord, mammary glands and 
other regions that regulate the milk-ejection reflex. To date, the regulatory mechanisms 
underlying the complex expression pattern of Foxb1 have not been elucidated. In order to 
identify conserved cis-regulatory elements of Foxb1, I aligned the fugu Foxb1 locus with 
the corresponding sequences in mouse and human, and characterized individual CNEs in 
transgenic mice embryos at different developmental stages. 
 
5.2 Comparison of Foxb1 loci in human, mouse and fugu 
Identification of Foxb1 ortholog in fugu using Ensembl Biomart annotation and 
INPARANOID showed that fugu contains a single ortholog. The genomic sequences for 
the human, mouse and fugu Foxb1 genes were retrieved from Ensembl (see Materials and 
methods).  Scanning of the genes located upstream and downstream of Foxb1 in the 
human, mouse and fugu genome assemblies indicated that the synteny of the genes in this 
locus is highly conserved in the three genomes (Figure 11). The protein sequence of 
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Foxb1 is encoded by a single exon in human, mouse and fugu. The 5’ and 3’ flanking 
sequences of Foxb1 span 325 kb and 350 kb in human, 230 kb and 270 kb in mouse and 
24 kb and 27 kb in fugu respectively (Figure 11). Therefore as with Six3, Foxb1 is 
situated in a vast sea of noncoding DNA and it can be a challenge to identify cis-
regulatory elements directing expression of Foxb1 gene in these vertebrates. The 
orthologous genomic sequences, comprising the entire 5’ and 3’ flanking regions, for 
each of the human, mouse and fugu genes were aligned using the global alignment 
algorithm MLAGAN (http://genome.lbl.gov/vista/lagan/) using fugu as the reference 
sequence and CNEs (>60% identity and larger than 50 bp) were predicted using VISTA. 
 
 
Figure 11: Foxb1 loci of human, mouse and fugu. Arrows indicate the direction of 
transcription. Foxb1 gene is indicated in orange while conserved syntenic genes are 
indicated in green. 
 
 
A total of 30 mammal-fugu CNEs were predicted in the Foxb1 loci (Figure 12). There are 
13 CNEs located in the 5’-flanking region, including one CNE (235 bp) situated just 200 
1000kb 
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bp upstream of the transcription initiation site and thus overlapping with the basal 
promoter and 5’UTR of Foxb1, while 17 CNEs are located in the 3’-flanking region. In 
the human genome, these CNEs are spread over a region of 440 kb with the most 
upstream and downstream CNE located about 125 kb and 315 kb respectively from the 
transcription start site. Due to the large number of CNEs and the enormous time 
constraints on testing them individually, I decided to pick only the CNEs most proximal 
to the gene for testing. For the purpose of testing these CNEs in transgenic mice, CNEs 
located in clusters were grouped together and their combined sequences were amplified 
by PCR while the rest were amplified as individual CNEs. The CNEs tested included the 
basal promoter which includes CNE3; CNE1 and CNE2 located upstream; and CNE4 and 
CNE5 located downstream of the coding sequence (Figure 13). The details of the CNEs 
tested are given in Table 5. In all, five conserved noncoding sequences were tested in 
transgenic mice. I first tested the function of the basal promoter (CNE3-P) alone by 
cloning it upstream of a β-galactosidase reporter, and then tested the functions of other 
CNEs by cloning each of them upstream of the basal promoter.  
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Figure 12: Conserved noncoding elements in the Foxb1 locus. VISTA plot of the 
MLAGAN alignment of the fugu, mouse and human Foxb1 loci is shown. Fugu was used 
as the base sequence. CNEs were predicted as noncoding sequences that are ≥60% 
identity across 50 bp or longer. Peaks represent conserved sequences; coding sequences 
are shaded blue and non-coding sequences (CNEs) are shaded pink. The arrow indicates 
the direction of transcription of Foxb1. There are 30 CNEs in total but only those 
enclosed in the red rectangles were analyzed for regulatory potential (see Figure 13 for a 
close-up view). X-axis represents fugu sequence and Y-axis represents percent identities 
(50%-100%). 
 











Figure 13: CNEs selected for testing in transgenic mice. The conserved noncoding 
peaks are shaded in pink and highlighted in red rectangle boxes. Three of the conserved 
peaks (designated CNE1-3) are located in the 5’ flanking region, including one that 
overlaps the basal promoter and 5’UTR. The other two conserved peaks (designated 
CNE4-5) are in the 3’ flanking region. The pink peaks outside the red boxes overlapped 
with NCBI EST sequences and were not counted as CNEs. 
 
 












CNE1 2 455 76.5 -6.7 kb 680 
CNE2 1 235 68.1 -4 kb 290 
CNE3 2 234 80.8 -200 bp 400 
CNE4 1 246 82.1 +3 kb 460 
CNE5 1 187 72.7 +34 kb 340 
 
Table 5: Foxb1 CNEs tested in transgenic mice. The length, percent identity and 
location of the CNEs are shown. The actual size of the mouse noncoding sequence 
amplified and cloned into a lacZ reporter construct is shown in the last column. TSS: 
transcription start site. 
 
 
5.3 Expression pattern of mouse Foxb1 
The expression pattern of Foxb1 in the mouse embryo during the early stages of 
development (embryonic days E9.5 to E11.5) and the late stages of development 
(embryonic days E13.5 to E15.5) has been previously investigated (Labosky et al., 1997; 
Wehr et al., 1997). However, for the sake of comparison of the expression pattern of the 
mouse Foxb1 gene with the expression pattern of the reporter gene driven by mouse 
Foxb1 CNEs, I determined the expression pattern of the Foxb1 gene in the FVB/N mouse 
strain used for testing the CNEs. The expression in the early stages of development 
(E9.5-E11.5) was analyzed by a whole-mount in situ hybridization using an antisense 
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RNA probe that binds specifically to a 450 bp fragment of the mouse Foxb1 coding 
region and the expression during the late stages of development was investigated by in 
situ hybridization of sagittal (E13.5) or coronal (E15.5) sections of the mouse embryos 
using the same probe. At E9.5, the expression of Foxb1 was detected in the presumptive 
diencephalon of the forebrain, midbrain, hindbrain and neural tube (Figures 14A and 
14B), in agreement with the expression patterns observed in previous studies (Labosky et 
al., 1997; Wehr et al., 1997; Zhao et al., 2007). At E10.5, expression intensified in the 
same domains but has also spread to include the developing telencephalon (Figures 14C 
and 14D). At E11.5, expression remained in the diencephalon, midbrain, hindbrain, and 
neural tube (Figure 14E) with more intense staining in the differentiated telencephalon. 
Foxb1 has not been known to express in the telencephalon in the handful of expression 
studies carried out so far, and previous staining observed in that region has been 
attributed to unspecific background (Wehr et al., 1997). At later stages of development 
(E13.5-E15.5), Foxb1 expression was predominantly seen in the hypothalamus and 
thalamus of the diencephalon (Figure 14F and 14G), with the transcripts localized to the 
differentiated nuclei of the mammillary bodies of the posterior hypothalamus (Labosky et 
al., 1997; Wehr et al., 1997) or in cells of the lateral hypothalamus (Kloetzli et al., 2001). 
In addition expression was also observed in the midbrain tegmentum and hindbrain as 
previously observed by Wehr et al (1997) and Zhao et al (2007) (Figures 14H and 14I). 
Thus, the expression profile I observed for Foxb1 in the hypothalamus and thalamus, the 
midbrain, hindbrain and spinal cord (neural tube) is generally consistent with that in the 
literature in both the early and late stages of development, with the mammillary bodies of 
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the hypothalamus being the major site of expression after midgestation, and additional 














Figure 14: Expression patterns of Foxb1 in the developing mouse embryo. (A-E) 
Whole mount in situ hybridization of wild type embryos showing expression of mouse 
Foxb1. At E9.5, mRNA accumulation was seen in the presumptive diencephalon of the 
forebrain, midbrain and hindbrain (A), as well as in the neural tube (B). At E10.5 
expression intensified in the diencephalon, midbrain, hindbrain (C), and neural tube (D). 
At E11.5, expression persisted in the diencephalon, the midbrain, the hindbrain and 
neural tube (E). Staining in the telencephalon is due to unspecific background. (F-I) In 
situ hybridization of sagittal (e13.5) and coronal (e15.5) sections of the head of wild-type 
embryos with a 450 bp fragment of the mouse Foxb1 exon as a probe at E13.5 (F, H) and 
E15.5 (G, I) show that mouse Foxb1 expression is primarily detected in the hypothalamus 
and thalamus of the diencephalon (F, G); as well as more weakly in the midbrain 
tegmentum and hindbrain (H, I). D: diencephalon; FB: forebrain; HT: hypothalamus; 




5.4 Functional assay of Foxb1 CNEs 
5.4.1 Basal promoter region (includes CNE3) of mouse Foxb1 is sufficient to 
recapitulate most aspects of endogenous expression during early and late stages of 
development 
I first tested the function of the promoter region alone to determine its contribution to the 
expression pattern of mouse Foxb1 gene. A 400 bp fragment of the mouse Foxb1 
promoter region, spanning from  -250 bp to +150 bp in relation to the transcriptional start 
site, was amplified and cloned upstream of a β-galactosidase reporter gene. This region of 
the promoter includes the highly conserved CNE3-P which spans from -200 to +34 bp. 
H I 
 100 
This construct did not show expression of the reporter gene in E9.5 embryos. However at 
E10.5, it showed reproducible expression in the prospective diencephalon, midbrain and 
hindbrain (Figure 15A) and this expression pattern persisted at E11.5 (Figure 15C). 
Ectopic expression was observed in the telencephalon at both stages. This expression 
profile is similar that of the endogenous mouse Foxb1 expression at E10.5 and E11.5 
stages, except that the promoter did not direct expression to the neural tube (Figures 15B 
and 15D). At later stages of E13.5 and E15.5, expression of the transgene was detected in 
the hypothalamus and thalamus of the diencephalon (Figure 15E and 15F); as well as in 
the midbrain tegmentum and hindbrain (Figure 15G). In addition, ectopic expression was 
observed in the striatum region of the telencephalon (Figure 15H). Overall, this construct 
directed expression in all the domains in which mouse Foxb1 is expressed during late 
embryo development, but it included ectopic expression in the telencephalon. These 
results indicate that the 400-bp promoter region is capable of reproducing expression of 










Figure 15: A 400-bp basal promoter region of mouse Foxb1 directs expression of 
lacZ mRNA to the diencephalon, midbrain and hindbrain during embryonic 
development. (A-D) Whole mount in situ hybridization of transgenic embryos show that 
the 400-bp promoter region directs expression of reporter gene in the diencephalon of the 
forebrain, midbrain and hindbrain at E10.5 (A) and at E11.5 (C), with ectopic expression 
detected in the telencephalon. No expression was directed to the neural tube at these 
stages (B, D). (E-J) In situ hybridization of sagittal (e13.5) and coronal (e15.5) sections 
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promoter region directs lacZ expression to the hypothalamus and thalamus of the 
diencephalon (E, F); and more weakly in the midbrain tegmentum and hindbrain (H). 
Ectopic expression was also detected in the telencephalon of the forebrain (G). D: 
diencephalon; FB: forebrain; HT: hypothalamus; MB: midbrain; T: telencephalon; Tg: 
tegmentum; Th: thalamus. Scale bar = 100µm unless otherwise indicated. 
 
 
5.4.2 Expression patterns directed by CNEs 1, 2, 4 and 5 
CNE1 consisted of 2 conserved fragments spanning a total of 455 bp and was amplified 
as a 680 bp sequence and cloned upstream of the mouse Foxb1 promoter (CNE3-P) 
construct. CNE2 was made up of one conserved 235 bp fragment and amplified as a 290 
bp fragment and cloned upstream of the mouse Foxb1 promoter. CNE4 comprised one 
conserved fragment of 246 bp of genomic sequence, and was cloned as a 460 bp fragment 
upstream of the promoter. CNE5 spanned 187 bp and was amplified as a 340 bp sequence 
cloned upstream of the promoter. Expression of these transgenes was then individually 
assayed across different time points using lacZ RNA probe in situ hybridization.  
 
At E9.5 CNE1 directed lacZ expression to the presumptive diencephalon, the midbrain 
and hindbrain (Figure 16A), but not in the neural tube. Expression at this stage was 
weaker compared to the endogenous gene expression (compare with Figure 14A). There 
was weak ectopic expression in the presumptive telencephalon region of the forebrain 
(Figure 16A). At E10.5, lacZ mRNA expression had intensified in the same domains 
(Figure 16B), and had started expressing in the neural tube (Figure 16C).  Expression 
remained in these domains of expression at E11.5 (Figures 16D and 16E). Therefore the 
effect of CNE1 on the promoter during early embryonic development was to direct early 
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expression at E9.5 to the diencephalon, midbrain and hindbrain, as well as to act as an 
enhancer for neural tube expression from E10.5 onwards.  
 
For CNE2, no expression was detected in transgenic embryos at E9.5. At E10.5, 
expression of the transgene was seen in the prospective diencephalon, the midbrain, 
hindbrain and neural tube (Figures 16F and 16G). There was ectopic expression in the 
prospective telencephalon that persisted till later developmental stages. This was similar 
to the basal promoter construct at the same stage (Figure 15A), except the additional 
neural tube expression and therefore CNE2 is likely to be a neural tube enhancer working 
in concert with the promoter at E10.5. However at E11.5, expression in the midbrain, 
hindbrain and neural tube were almost completely abolished (Figure 16H) while that in 
the diencephalon remained (Figure 16I). These results showed that CNE2 acted as an 
enhancer of the neural tube only at E10.5 and was a silencer of expression in the 
midbrain and hindbrain at E11.5.  
 
CNE4 directed transgene expression as early as E9.5 to the presumptive diencephalon, 
midbrain and hindbrain with ectopic expression observed in the presumptive 
telencephalon (Figure 16J). However at E10.5 expression was detected only in the 
diencephalon and ectopically in the telencephalon (Figure 16K). It therefore acted as an 
early enhancer for Foxb1 expression at E9.5, as well as a midbrain and hindbrain silencer 
at E10.5 (Figure 16L). At E11.5, expression was detected in the diencephalon and 
restored in the midbrain and hindbrain. In addition, ectopic expression was observed in 
the telencephalon (Figure 16M). There was no neural tube expression (Figure 16N), 
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which meant the expression at E11.5 completely overlapped with that of the basal 
promoter and CNE3 had no observable effect on the promoter at this particular stage.  
 
CNE5 directed no visible expression in E9.5 transgenic embryos but at E10.5 expression 
was detected in the presumptive diencephalon, the midbrain, hindbrain and neural tube 
(Figures 16O and 16P), with ectopic expression in the presumptive telencephalon. At 
E11.5, expression was abolished in the neural tube but remained in the other domains 
(Figure 16Q), indicating CNE5 acted solely as a neural tube enhancer at E10.5 in its 
interaction with the promoter. At later stages of E13.5 and E15.5, all four constructs 
(CNE1, CNE2, CNE4 and CNE5) directed expression to the hypothalamus and thalamus; 
midbrain tegmentum; and hindbrain; as well as ectopically in the telencephalon (data not 
shown). This overlapped completely with the basal promoter expression, and showed that 
CNE1, CNE2, CNE4 and CNE5 had no observable phenotypic effect on the promoter 
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Figure 16: Whole mount in situ hybridization showing expression patterns directed 
by mFoxb1 CNE1, CNE2, CNE4 and CNE5. (A-E) CNE1 and mFoxb1 basal promoter 
drove lacZ mRNA expression to the diencephalon, midbrain and hindbrain at E9.5 (A), 
E10.5 (B) and E11.5 (D), and activated neural tube expression at E10.5 (C) and E11.5 
(E). (F-I) CNE2 and basal promoter directed expression to the diencephalon, midbrain, 
hindbrain (F) as well as in the neural tube (G) at E10.5, but at E11.5 it diminished 
expression in the midbrain and hindbrain (H) while maintaining expression in the 
diencephalon (I). CNE4 with the basal promoter gave rise to early expression in the 
presumptive diencephalon, midbrain and hindbrain at E9.5 (J), silenced expression 
partially in the midbrain and hindbrain at E10.5 (K, L), and restored expression in the 
same domains again at E11.5 (M, N). (O-Q) CNE5 with the promoter directed expression 
to the diencephalon, midbrain and hindbrain (O), as well as to the neural tube at E10.5 
(P). Neural tube expression was abolished while the other expression domains remained 
at E11.5 (Q). Ectopic expression was observed in the presumptive telencephalon for all of 




5.4.3 Summary of the regulatory potential of mouse Foxb1 CNEs 
The CNEs I analyzed from the mouse Foxb1 locus all functioned as tissue-specific 
enhancers and / or silencers in transgenic mouse embryos. CNE3-P and its flanking 
sequences that represent the basal promoter tested directs expression to almost all 
domains of the endogenous mouse Foxb1 expression in both the early and late stages of 
embryo development, while the other CNEs work in concert with the basal promoter to 
silence or enhance expression in certain domains at particular stages of development. 
Table 6 provides a summary of the effect of each CNE on the expression pattern driven 
by the mouse Foxb1 promoter and clearly shows their overlapping roles in modulating 
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Table 6: Enhancer function of mouse Foxb1 CNEs across different developmental 
stages and in different tissues. CNE3 is part of the basal promoter tested. Other CNEs 
were cloned upstream of the basal promoter (CNE3-P) and expression pattern was 
assayed using in situ hybridization that detected lacZ mRNA and compared with that 
driven by the basal promoter alone. The differences in the expression pattern conferred 
by each CNE are then tabulated. D: diencephalon; HB: hindbrain; HT: hypothalamus; T: 
telencephalon; Th: thalamus. 
 
 
5.4.4 Conservation of regulation of Foxb1 between fugu and mouse 
A prediction from Table 6 would be if the basal promoter (CNE3-P) was working in 
concert with CNEs1, 2, 4 and 5 at the same time, Foxb1 expression in the diencephalon, 
midbrain and hindbrain would be detected by E9.5 (activated by CNEs1 and 4), and 
expression in the midbrain and hindbrain modulated by CNEs 2 and 4 at E10.5-E11.5 so 
that the primary expression domain would be the diencephalon that would differentiate to 
form the hypothalamus and thalamus where Foxb1 would be primarily expressed in the 
later stages of embryonic development (directed by basal promoter). In addition, neural 
tube expression would be detected from E10.5 (activated by CNEs1, 2 and 5), while 
ectopic expression in the telencephalon would be observed from E9.5. I decided to 
validate the combined regulation of Foxb1 by the 5 CNEs including the basal promoter 
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by using the orthologous fugu DNA sequences to determine if this regulation was 
conserved between mouse and fish in spite of the slight differences in their sequences 
(the identity between mouse and fugu CNEs is 68% to 82%). Since the intergenic regions 
in fugu were much shorter than in mice, I could amplify CNEs 1 and 2 as a single 1.2 kb 
fragment, and CNEs 4 and 5 as a single 0.9 kb fragment. These fragments were cloned 
upstream of the fugu basal promoter (CNE3-P) linked to the β-galactosidase reporter such 
that the construct contained CNEs 4+ CNE5 +CNE1 +CNE2 upstream of the fugu basal 
promoter. This construct was then tested in transgenic mice and expression was assayed 
at various stages of development using in situ hybridization of lacZ riboprobe as 
previously described. 
 
Expression was detected from E9.5 in the prospective diencephalon, midbrain and 
hindbrain, with ectopic expression observed in the prospective telencephalon (Figure 
17A). At E10.5, expression intensified in the above-mentioned domains (Figure 17B), 
and was first detected in the neural tube (Figure 17C). At E11.5, expression remained in 
the diencephalon, midbrain, hindbrain and neural tube, as well as ectopically in the 
telencephalon (Figures 17D and 17E). At later stages of development (E13.5-E15.5), 
transgene expression was observed primarily in the hypothalamus and thalamus (Figure 
17F), as well as in the midbrain and hindbrain (Figure 17G). Ectopic expression was also 
observed in the striatum of the telencephalon during these stages. Therefore this fugu 
construct that combined all 5 CNEs has reproduced almost all of the endogenous gene 
expression in both early and late stages of development. The exceptions were the lack of 
neural tube expression and the lack of inhibition of ectopic expression in the 
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telencephalon both at stage E9.5. These results show that the mouse transcriptional 
machinery was able to interact with the fugu basal promoter and enhancers and direct 
tissue-specific expression similar to the expression pattern of the endogenous mouse 
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Figure 17: A fugu construct containing CNEs 1, 2, 4 and 5 upstream of the basal 
promoter containing CNE3 reproduces mouse endogenous Foxb1 expression in the 
diencephalon, midbrain and hindbrain. (A-E) Whole mount in situ hybridization of 
transgenic embryos show that the fugu construct directed expression of reporter gene in 
the diencephalon of the forebrain, midbrain and hindbrain from E9.5 (A). Ectopic 
expression was also detected in the telencephalon (A). No expression was directed to the 
neural tube at this stage. Expression intensified at E10.5 (B) and in addition was detected 
in the neural tube (C). At E11.5 expression remained in the above mentioned domains (D, 
E). (F-G) In situ hybridization of  sagittal (e13.5) and coronal (e15.5) sections of the head 
of transgenic embryos at E13.5 (F) and E15.5 (G) showed that the fugu construct directed 
lacZ expression to the hypothalamus and thalamus of the diencephalon (F); and more 
weakly in the midbrain and hindbrain (G). Ectopic expression was also detected at these 
stages in the telencephalon. D: diencephalon; FB: forebrain; HT: hypothalamus; MB: 






Foxb1 is an important regulator of the organization of the diencephalon during vertebrate 
forebrain development (Alvarez-Bolado et al., 2000). Defining the precise gene 
regulatory network that controls its spatiotemporal expression would help in elucidating 
the mechanisms by which it regulates forebrain development. This study has allowed a 
better understanding of the transcriptional mechanisms responsible for regulating Foxb1 
expression in a tissue and developmental-stage specific manner. Firstly, CNE3 together 
with the flanking sequences representing the basal promoter was able to specify the 
F G 
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prospective diencephalon, midbrain and hindbrain expression from E10.5, maintain it at 
E11.5, and by later stages (E13.5-E15.5) direct expression to the differentiated 
diencephalon (hypothalamus and thalamus), midbrain tegmentum and hindbrain. This 
implies that the basal promoter can direct expression to the majority of the endogenous 
mouse Foxb1 expression domains. However, it is not clear if this expression pattern is 
due to the CNE3 sequence or the sequences flanking it in the basal promoter construct 
tested or a combination of both, although the high level of conservation of CNE3 
suggests that it is most likely playing a role in the expression patterns observed with this 
construct. In the early developmental stages of E10.5-E11.5, the basal promoter alone 
was sufficient to reproduce endogenous gene expression levels in the diencephalon, 
midbrain and hindbrain; but it did not specify neural tube expression that was part of the 
early expressing Foxb1 domains in mouse. In addition, it did not down-regulate 
expression in the telencephalon at E10.5-E11.5, which was consistent with what I 
observed for the endogenous gene expression pattern at these stages of development. In 
the later stages of development, the promoter was sufficient to direct expression to the 
hypothalamus and thalamus, as well as to the differentiated midbrain and hindbrain, 
reproducing completely the endogenous gene expression level. However there was 
ectopic expression in the striatum of the telencephalon, which was not down-regulated at 
these later stages. Therefore a silencer located in this locus is likely to be involved in 
suppressing the expression of the basal promoter in the telencephalon to ensure the 
correct expression of Foxb1 during embryonic development. 
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Secondly, the four CNEs in the Foxb1 locus acted as enhancers and/or silencers with 
overlapping functions. The functions of individual enhancers that were ‘added on’ to the 
basal promoter construct can be deduced by a comparison of expression patterns resulting 
from the effect of individual CNEs on the basal promoter, with that observed due solely 
to the action of the basal promoter. I found two early enhancers (CNEs 1 and 4) that 
directed expression to the presumptive diencephalon, midbrain and hindbrain at E9.5, 
reproducing endogenous gene expression at that stage. Again there was ectopic 
expression in the presumptive telencephalon at this stage that was not present in the 
endogenous gene expression pattern. In the genomic context of the Foxb1 locus, these 
early enhancers would have had to be modulated or silenced by other cis- and/or trans-
acting agents, so as not to give rise to ‘leaky’ expression in the telencephalon. I found 
such silencers or modulators for midbrain and hindbrain expression in CNEs 2 and 4 at 
E11.5 and E10.5 respectively. It is likely they are required to inhibit midbrain and 
hindbrain expression incompletely so as to establish a gradient of expression from the 
rostral end to the caudal end in the midbrain and hindbrain observed during these stages 
that is crucial for midbrain development (Wehr et al., 1997). In addition, there were three 
enhancers that gave rise to neural tube expression and this also complemented the action 
of the promoter to specify the endogenous Foxb1 expression domains at the appropriate 
stages. CNE1 specified neural tube expression from E10.5 to E11.5 (CNE1) while CNE2 
and CNE5 were activated only at E10.5. Neural tube expression of Foxb1 is observed in 
early to mid gestation (E9.5-E11.5) before expression becomes restricted to the 
hypothalamus, midbrain and hindbrain (Labosky et al., 1997; Wehr et al., 1997).  
Therefore the neural tube enhancers are only required for a short time in development, 
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and this could explain their functional segregation from the promoter which specifies 
more persistent expression that will last through embryonic development till after birth. 
 
The validation of a transgene containing the fugu orthologs of CNEs 1 to 5 linked to the 
fugu promoter reproduced almost all the effects of individual mouse CNEs in concert 
with the mouse basal promoter in specifying most domains of embryonic mouse Foxb1 
expression. However the silencing effects of mouse CNEs 2 and 4 in modulating 
expression in the midbrain and hindbrain could not be observed. This could be due to the 
presence of additional enhancers present in the fugu CNEs that also directed midbrain 
and hindbrain expression; or the presence of silencer blockers that neutralized the 
silencing effects of CNEs2 and 4 at E11.5 and E10.5 respectively. Alternatively, the 
function of these silencers may not be conserved in the fugu CNEs. This conservation of 
function of fugu and mouse CNEs despite the slight differences in their sequences 
indicated that the core sequence that is totally conserved in the two species are important 
for the expression of the CNEs.  
 
The in vivo validation of CNEs proximal to the Foxb1 locus reveals some clues on the 
regulatory logic of Foxb1. Firstly, the basal promoter containing CNE3 specifies the 
primary domains of Foxb1 both in the early and late stages of development (Figure 18A). 
This includes the diencephalon that later develops to form the hypothalamus and 
thalamus; the midbrain and the hindbrain. Secondly, the CNEs act to modulate the basal 
promoter. For example they can act as temporal enhancers to the basal promoter (CNEs 1 
and 4, Figure 18B); or they can act as modulators of the primary expression domains 
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(CNEs 2 and 4, Figure 18C); or they can act as enhancers of secondary expression 
domains like the neural tube (CNEs 1, 2 and 5, Figure 18D); or they can act as silencers 
of ectopic expression by the basal promoter like in the telencephalon. For the latter, none 
of the CNEs I tested had this function. Such a silencer would likely to be present in the 
more distant CNEs since the presence of this silencer is needed to ensure correct 
expression of Foxb1. Thirdly, the conservation of the regulatory organization and 
information of Foxb1 in mouse and fugu through the validation of a handful of CNEs 
indicate this regulatory logic is likely to be conserved in all vertebrates and is crucial for 
the proper expression of Foxb1 in embryonic development.  
 
This study has focused primarily on the developing embryonic brain as the site of Foxb1 
expression studies. It must be pointed out that Foxb1 also expresses in the mammary 
gland epithelium from embryonic to adult stages. Expression starts off at about E12.5 
days and is restricted to the epithelial cells of the embryonic gland, before expanding 
after birth to the epithelial cells in the nipple anlage and those lining the ducts of the 
mature mammary gland (Kloetzli et al., 2001). As such, expression during late embryonic 
development in the embryonic gland was not readily observable and time constraints did 
not permit me to analyze the stronger mammary gland expression in the adult stage. 
Expression of Foxb1 in the mammillary bodies in the hypothalamus during embryonic 
development and in the mammary gland epithelium during adult development is likely to 
be crucial for the regulation of the milk ejection reflex and the ability to lactate in 
mammals. However fishes do not have mammary glands, so it is doubtful if regulation of 
Foxb1 in mammary gland is conserved in fish. Nevertheless, the use of fugu to identify 
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cis-regulatory elements of Foxb1 expression in the developing mouse embryonic brain 
and the ability of fugu CNEs to direct similar expression as the mouse CNEs to the 
different brain domains has shown that regulation is conserved at the level of 
hypothalamus, thalamus, midbrain and hindbrain expression, and the organization and 




Figure 18: Summary of the regulatory code that controls the expression of Foxb1 in 
mouse. (A) The basal promoter (CNE3-P) alone directs expression to the diencephalon, 
midbrain and hindbrain in the early stages of development from E10.5; as well as to the 
differentiated hypothalamus, thalamus, midbrain and hindbrain during the later stages of 






hindbrain at E9.5 is mediated by at least two enhancers (CNE1 and CNE4). (C) 
Expression of Foxb1 in the midbrain and hindbrain during early development is 
modulated by at least two silencers (CNE2 and CNE4) that incompletely repress 
expression at E10.5-E11.5. (D) Neural tube expression of Foxb1 is mediated by at least 
three enhancers (CNE1, CNE2 and CNE5) during early development at e10.5-E11.5. D: 
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In vertebrates, the hypothalamus plays a key role in the regulation of nutritional status 
and energy homeostasis through the coordination of many neurotransmitter systems. One 
such system is the recently discovered orexin-A and orexin-B (also known as hypocretin-
1 and hypocretin-2) and their family of receptors. Orexin-A and -B are proteolytically 
derived from a single precursor protein encoded by the prepro-orexin gene (ORX). They 
were first discovered as ligands that bound to orphan G-protein coupled receptors in the 
rat brain, and their cDNAs were subsequently cloned (de Lecea et al., 1998; Sakurai et 
al., 1998). Since then, ORX gene has been cloned from several mammals including 
human (Sakurai et al., 1999), mouse (Chemelli et al., 1999), dog (Lin et al., 1999), pig 
(Dyer et al., 1999) and sheep (Archer et al., 2002). ORX mRNA and immunoreactive 
orexin-A are highly localized to distinct neurons in the lateral hypothalamic area (LHA) 
that has been regarded as the 'feeding center' (Nambu et al., 1999). Orexin neurons, 
however, innervate most regions of the central nervous system including various regions 
in the cerebral cortex, limbic system, and brain stem (Peyron et al., 1998). Besides 
mammals, ORX gene has also been cloned from Xenopus laevis (Shibahara et al., 1999), 
chicken (Ohkubo et al., 2002) and zebrafish (Kaslin et al., 2004). It has been found that 
the general organization of the ORX system of the brain, which includes a hypothalamic 
cell cluster and widespread fiber projections, seems to be conserved among vertebrates 
(Kaslin et al., 2004). 
 
Orexins play a key role in regulating feeding behavior and states of sleep and 
wakefulness. Intracerebroventricular administration of orexins to rats led to a significant 
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increase in food consumption (Sakurai et al., 1998). Furthermore, the expression levels of 
rat ORX are upregulated in response to fasting (Sakurai et al., 1998) and insulin-induced 
hypoglycemia (Moriguchi et al., 1999) indicating a role for orexins in regulating feeding 
behavior.  Interestingly, the targeted disruption of ORX in mouse resulted in an autosomal 
recessive phenotype with characteristics similar to human narcolepsy (Chemelli et al., 
1999). Subsequent studies in genetically narcoleptic dogs identified a mutation in the 
ORX2R gene (Lin et al., 1999). Although no mutations were found either in the ORX or 
ORX2R gene in human narcoleptics, a significant reduction in the number of ORX 
neurons and reduced ORX content in the cerebrospinal fluid was noted in such 
individuals (Thannickal et al., 2000). Conversely direct injection of ORX protein into the 
brain increases locomotor activity and decreases sleep for a few hours in mice (Mieda et 
al., 2004) and overexpression of ORX induces an insomnia-like phenotype in zebrafish  
(Prober et al., 2006). These findings show that orexin neuropeptide system plays a 
significant role in the regulation of sleep-wakefulness in mammals besides regulating the 
feeding behavior, and it has been proposed that the ORX system drives the aminergic and 
cholinergic system to control sleep and wakefulness states because of its widespread 
projections to the aminergic and cholinergic cell clusters (Kaslin et al., 2004). In fact the 
extensive projections of orexinergic neurons in the entire central nervous system (Cutler 
et al., 1999; Nambu et al., 1999) suggest that ORX may be involved in many other 
physiological functions, including the control of neuroendocrine systems and the 
autonomic nervous system (Johren et al., 2001). 
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The highly specific expression of ORX in the ‘orexinergic’ neurons of the LHA indicates 
a tight mechanism of regulation in the brain. To date there have been two main studies 
carried out in mice and zebrafish that have helped to elucidate the regulatory mechanisms 
of ORX. A 3.2 kb 5’flanking region of human ORX has been shown to be sufficient to 
direct expression to orexinergic neurons in the LHA of transgenic mice (Moriguchi et al., 
2002) while in another study, a 1 kb 5’ flanking region of zebrafish ORX has been shown 
to be sufficient for driving cell-specific expression in the LHA in transgenic zebrafish 
(Faraco et al., 2006). In my efforts to identify CNEs in genes that express in the brain, I 
did not identify any CNEs in the human, mouse and fugu ORX loci. Since the expression 
pattern is conserved in these vertebrates, I was interested to see how the regulation is 
conserved despite of absence of CNEs in this locus. To address this I expressed the fugu 
ORX gene in transgenic mice to determine if the regulatory mechanism is conserved 
between mammals and fish and then I made deletions in the promoter region to identify 
the regulatory elements common to mammals and fish. 
 
6.2 Comparison of ORX loci in human, mouse and fugu 
I annotated all the genes present on the fugu ORX scaffold #424 (131 kb) based on their 
homology to known sequences in the NCBI database (see Materials and Methods). The 
fugu scaffold contains six genes besides ORX gene. These six genes are: signal transducer 
and activator of transcription 5 gene (STAT 5); phospholipase C-ε2 gene (PLC-E2); 
potassium voltage-gated channel protein subfamily H4 gene (KCNH4); a member of RAS 
oncogene family (RAB5C); transcriptional adaptor for general control of amino acid 
synthesis gene (GCN5L2), and a hypothetical protein LGP2 gene (Figure 19). The fugu 
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ORX gene is flanked by PLC-E2 at 2.2 kb upstream (from the polyadenylation signal of 
PLC-E2 to the transcription start site of ORX) and KCNH4 at 1.38 kb downstream (from 
the polyadenylation signal of ORX to the first codon of KCNH4). Comparisons of the 
fugu ORX locus with the human and mouse ORX loci show that the order and orientation 
of six of the fugu genes are conserved in the human and mouse loci (Figure 19). The 
order of genes in the human and mouse loci are totally conserved. Interestingly, the 
human and mouse loci contain two STAT5 (5A and 5B) genes as compared to the single 
STAT5 gene present at the 5' end of the fugu scaffold. The two STAT5s in the human and 
mouse loci are linked head to head suggesting that they arose through tandem duplication 
in the mammalian lineage.  Alternatively, following the duplication of STAT5 gene in a 
common ancestor of mammals and fishes, one copy may have been lost in the fugu 
lineage.  
 
Figure 19: ORX locus in fugu, mouse and human. Arrows represent genes and indicate 
the direction of transcription. The gene order at the human and mouse loci were obtained 
from the UCSC Human Genome Browser (http://genome.ucsc.edu).  ORX gene is 
indicated in orange while other syntenic genes are indicated in green. Fugu cosmid 33B9 
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Comparison of non-coding sequences across evolutionarily distant vertebrates is a 
powerful strategy for identifying conserved cis-regulatory elements. Unfortunately 
aligning the noncoding regions of ORX in human, mouse and fugu using MLAGAN at a 
sensitive threshold of 60% identity and 50 bp window size did not identify any CNEs. In 
order to determine how in the absence of a conserved regulatory element the tissue-
specific expression of ORX is achieved, I decided to find out firstly if the fugu ORX gene 
is regulated in the same way as the mouse gene, after which I could then localize the 
regulatory region in the fugu gene by progressive deletion of its locus.  
 
6.3 Expression of fugu ORX in mouse 
The fugu scaffold sequence surrounding the ORX gene contained several gaps. To fill the 
gaps and to make constructs for transgenic studies, I isolated fugu cosmids for this locus 
(see Materials and Methods). Cosmid 33B9 with an insert size of about 39 kb was 
selected as a representative clone for sequencing and gap filling. Annotation of the 
cosmid showed it contained the fugu ORX locus with its complete flanking sequences, 
together with the full coding region of PLC-E2 upstream and part of the coding region of 
KCNH4 downstream (Figure 19). Transgenic mice were then generated using the full 
cosmid sequence as described in Materials and Methods. Because the level of ORX 
expression gradually increases during postnatal development, analysis was performed 
using transgenic founder mice at 8-10 weeks of age (Moriguchi et al., 2002). The brains 
of the transgenic mice were removed and frozen, and coronal sections of the 
hypothalamus were taken. In situ hybridization was then carried out using an antisense 
RNA probe that binds specifically to a 320 bp fragment of the fugu ORX coding region. 
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The endogenous mouse ORX expression was detected by in situ hybridization using a 
RNA probe that binds to a 380 bp fragment of the mouse ORX coding region. This 
endogenous gene expression pattern was consistent with previous analyses (Moriguchi et 
al., 2002; Sakurai et al., 1999) in labeling specific neurons in the LHA (Figures 20A, C 
and E) and was carried out for the sake of comparison of the expression pattern of the 
mouse ORX gene with the expression pattern of the fugu ORX gene driven by its own 
regulatory region. The 43-kb cosmid (33B9) directed fugu ORX mRNA specifically in 
the mouse neurons in the LHA (Figures 20B, D and F). Indeed all 3 transgenic founder 
mice generated showed this LHA staining in specific neurons with no ectopic signal 
detected. To determine if the fugu cosmid directed ORX expression to the same LHA 
neurons as the mouse ORX, I did a double in situ hybridization in which mouse ORX 
neurons were stained light brown (Figure 20G) and fugu ORX neurons were stained red 
(Figure 20H). Both transcripts were found to be colocalized in the same neurons, as 
evident from the reddish brown staining of the neurons (Figure 20I). Thus, this 
experiment demonstrated that the fugu cosmid contained all the regulatory elements 
needed for directing fugu ORX to the mouse LHA neurons that express the endogenous 
mouse ORX, and that fugu ORX is therefore regulated the same way as mouse ORX. The 
question then was where the regulatory elements are located and whether their sequences 
in mouse and fugu are different. 
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Figure 20: Expression of fugu ORX gene in transgenic mice compared with the 
expression of the endogenous mouse ORX expression. In situ hybridization of coronal 
sections of the hypothalamus of transgenic mice expressing a fugu ORX cosmid was 










H) or the colocalization of both signals in the same LHA neurons (I). LHA: lateral 
hypothalamus; 3V: third ventricle. Scale bars: 200 µm in A and B; 50 µm in C and D; 10 
µm in E-I. 
 
 
6.4 Comparative analyses and validation of ORX regulatory elements common in 
human, mouse and fugu 
A 3.2 kb 5’flanking region of human ORX has been shown to be sufficient to direct 
expression to orexinergic neurons in transgenic mice (Moriguchi et al., 2002).  Further 
analysis of this promoter region identified two elements (OE1: 214 bp located 287 bp 
upstream and OE2: 217 bp located 2.5 kb upstream of the transcription initiation site of 
human ORX) that are conserved in humans and mouse, and essential for the expression in 
the LHA and for the repression in medial regions of the hypothalamus, with a core 57 bp 
being critical for the regulatory function of OE1 (Moriguchi et al., 2002). In addition, 
another study has shown that a 1 kb 5’ flanking region of zebrafish ORX is sufficient for 
driving cell-specific expression in the LHA in transgenic zebrafish (Faraco et al., 2006). 
Further analysis of this promoter region and comparison of motifs with other teleost 
fishes including fugu identified a critical 250 bp element containing a core 13 bp essential 
for ORX expression (Faraco et al., 2006). Interestingly there was no overlap between both 
the 57 bp OE1 core and the 13 bp zebrafish core elements, and the human 3.2 kb ORX 
promoter region did not specify any reporter expression in transgenic zebrafish, 
indicating the regulation of ORX in mammals is likely to be different from that in fish 
(Faraco et al., 2006). 
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The fugu ORX 5’ flanking region spans about 2.2 kb. Alignment of this region with the 5’ 
flanking regions in human and mouse was carried out using the ClustalW algorithm and 
the alignment was inspected by eye to determine if there was orthologs for OE1 and OE2 
elements in fugu. Comparison of fugu ORX 5’ flanking region with the 3.2 kb human and 
mouse ORX regulatory regions identified a 50 bp element in the fugu promoter that 
showed 44% similarity to the 57-bp core element in the mammalian OE1 (Figure 21A).  
The fugu element contains three deletions compared to the mammalian element. In the 
same way a 145 bp element was identified about 1 kb upstream of the fugu OE1 that 
showed 45% identity with mammalian OE2 element (Figure 21B). Although the 
sequence similarity suggests that the fugu elements are analogous to the mammalian OE1 
and OE2 elements, the function of the fugu elements would need to be confirmed in 
transgenic experiments.   
 
In the zebrafish study, Faraco et al. (2006) could identify conservation of regulatory 
motifs in the flanking regions of ORX from zebrafish, Tetraodon, fugu, medaka and 
stickleback in the 500 bp upstream of the TATA boxes, and the deletion of the region 
from -500 to -250 in the 1 kb zebrafish promoter construct resulted in a complete loss of 
reporter expression in transgenic zebrafish. In this crucial 250-bp region, there were 4 
regions containing clusters of identical residues conserved between zebrafish and 
Tetraodon, and these were subjected to site-directed mutagenesis. Mutations in 3 of these 
regions (1, 3 and 4) reduced the efficiency of the zebrafish ORX promoter moderately, 
but complete deletion of region 2 (13 bp) totally abolished the activity of the 1 kb 
promoter construct (Faraco et al., 2006). Since this crucial 250 bp region would overlap 
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with the location of fugu OE1, I checked manually to see if fugu OE1 would match any 
of the 4 conserved motifs listed in the zebrafish study (Faraco et al., 2006). Indeed there 
is a good match for region 1 in fugu OE1 in which 6 out of 10 residues are conserved 
between fugu and zebrafish; as well as for region 2 in fugu OE1 in which 6 out of 13 




 (B) OE2: 
 
 
Figure 21: Poorly conserved mouse and human regulatory elements in the fugu ORX 
locus. Conserved bases of OE1 (A) and OE2 (B) are shown by asterisks and dashes. The 
57-bp core element of OE1 in the human ORX promoter characterized by Moriguchi et al. 
(2002) is underlined. Two of the four conserved motifs investigated by Faraco et al. 
(2006) that could be identified in fugu OE1 are indicated in red. The numbers flanking 
the sequences are nucleotide positions in relation to transcription start site of ORX. 
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To identify the importance of conserved OE1 and OE2 elements in fugu, I generated a 
construct spanning the fugu ORX locus and containing the putative OE1 and OE2 
elements (N-fORX-K) by making deletions of cosmid 33B9 using the restriction enzymes 
NheI and Kpn1. This construct is 2.5 kb long and includes about 2 kb of the 5’ flanking 
sequence containing OE1 and OE2, as well as the coding sequences of the gene, with the 
3’ flanking sequence removed (Figure 22). Three of seven N-fORX-K transgenic founder 
mice showed fugu ORX mRNA labeling in specific neurons in the LHA, similar to the 
expression of the fugu cosmid but with lower intensity (Figure 23A). There was no 
ectopic expression observed. Double in situ hybridization indicated the endogenous 
mouse ORX mRNA stained as light brown neuronal cells (Figure 23B) and fugu ORX 
mRNA from N-fORX-K stained as blue neuronal cells (Figure 23C) colocalized in the 
same LHA neurons (Figure 23D). To further delineate the contributions of fugu OE2 and 
OE1 elements to the expression in LHA neurons, I cloned fugu OE2 (220 bp) and the 
fugu ORX basal promoter (545 bp) containing OE1 upstream of a β-galactosidase reporter 
(construct fOE2OE1-lac; Figure 22) and generated transgenic mice carrying this 
construct. Remarkably double in situ hybridization using lacZ-specific RNA probe 
showed that the transgene expression (Figure 23E) is localized to the same LHA neurons 
as the mouse ORX (Figure 23F), indicating the crucial regulatory elements directing 
LHA-specific neuronal expression was likely to be contained in OE1 and OE2 in fugu. 
However there was some ‘leaky’ expression of the N-fORX-K and fOE2OE1-lac 
transgenes since not all the neurons expressing the transgene in a blue signal overlapped 
with the brown endogenous signal (Figures 23D and F). To determine if fugu OE1 alone 
was sufficient to direct expression in the LHA, I generated a construct containing only 
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OE1 in the basal promoter cloned upstream of the β-galactosidase reporter (construct 
fOE1-lac; Figure 22). The minimal construct fOE1-lac containing OE1 within the fugu 
basal promoter failed to direct lacZ mRNA expression to neurons in the LHA of all five 
transgenic founder mice. This indicated that fugu ORX expression in the LHA require the 
cooperation of both OE1 and OE2 elements. The results of the characterization of the 
fugu ORX locus sequences in transgenic mice are summarized in Figure 22. 
 
 
Figure 22: Analysis of the regulatory region of fugu ORX in transgenic mice. The four 
transgene constructs tested prepared using cosmid 33B9 are depicted on the left and the 
number of founder mice showing LHA expression (fORX+) compared to the total 




   
  
   
Figure 23: Expression of fugu ORX in transgenic mice compared with the expression 
of the endogenous mouse ORX. In situ hybridization of coronal sections of the 
hypothalamus of transgenic mice expressing N-fORX-K (A-D) and fOE2OE1-lac (E-F) 
was carried out to detect fugu ORX expression (A, C, E), mouse ORX expression (B) and 








Comparison of non-coding sequences across evolutionarily distant vertebrates is a 
powerful strategy for identifying conserved regulatory elements that are common to all 
vertebrates. The fugu is a model genome to characterize genes and gene regulatory 
regions because of its compact genome size and short intergenic regions that contain very 
little repetitive sequences (Aparicio et al., 2002). In this study, I analyzed the regulatory 
mechanisms governing fugu ORX gene expression using a transgenic mouse assay in 
order to shed more light on the regulation of ORX in vertebrates and what specifies its 
precise and exclusive expression in neurons of the hypothalamus. I analyzed 131 kb from 
the fugu ORX locus and showed that the synteny of genes in this locus is conserved in the 
human and mouse ORX loci. However alignment of the ORX loci in human, mouse and 
fugu did not turn up any CNEs in the regulatory regions. To determine if fugu ORX was 
regulated the same way as the mammalian ORX, I generated transgenic founder mice 
expressing a 43 kb fugu cosmid (33B9) containing the complete ORX locus with flanking 
sequences and genes. Remarkably, the fugu ORX transgene was expressed in specific 
neurons of the LHA in which the endogenous mouse ORX gene is expressed. This result 
shows that the mouse transcriptional machinery was able to interact with the enhancers 
and the basal promoter of the fugu ORX gene located in the fugu cosmid and direct 
tissue-specific expression to the same neurons as the endogenous mouse gene, despite the 
apparent lack of sequence conservation in the regulatory regions of fugu and mouse ORX.  
 
Previously work done to analyze the 3.2 kb 5’ regulatory region of human ORX by 
comparison with the mouse locus uncovered two patches of conserved sequences 
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designated OE1 and OE2 elements. OE1 was shown to be required to activate ORX 
expression in the LHA and repress it in the medial regions of the hypothalamus in tight 
cooperation with OE2 to regulate ORX expression specifically in the LHA (Moriguchi et 
al., 2002). Further characterization of OE1 in transgenic mice showed that a 57-bp core 
region present within OE1 is critical for neuronal expression in the LHA and is likely to 
be made up of multiple cis-regulatory modules (Moriguchi et al., 2002). A closer analysis 
of the fugu ORX 5’ flanking sequence for conserved motifs helped me to uncover a 50 bp 
element orthologous to the 57 bp core of OE1 and located 322 bp upstream of fugu ORX. 
This fugu OE1 core element and the mammalian OE1 core only shared a 44% identity 
and hence it was not picked up in the 60% identity threshold I used for MLAGAN. In the 
same way, a fugu ortholog of OE2 was also detected a further 1 kb upstream of OE1 at 
45% identity with the mammalian OE2 element.  
 
The presence of sequences with similarity to mouse OE1 and OE2 elements in the fugu 
ORX locus despite their low conservation, suggest that they could be responsible for 
directing expression of fugu ORX in LHA-specific neurons in the same way as in human 
and mouse. This is supported by the observation that when transgenic constructs 
containing the fugu OE1 and OE2 elements (N-fORX-K and fOE2OE1-lac) directed 
transgene expression to neurons in the LHA in which colocalization of the endogenous 
mouse gene expression was also observed. While both transgene constructs were able to 
drive expression to the LHA, the expression levels were significantly lower than that 
observed with the entire cosmid 33B9, and there was leaky expression of the transgene in 
some neurons in the LHA that do not express the mouse ORX.. These results suggest that 
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the fugu cosmid contained additional enhancer elements outside the sequences of the two 
shorter constructs used. At the same time they also indicate the fugu cosmid contained 
silencers that helped to restrict the expression to only the LHA neurons. These additional 
enhancer and silencer elements could be present in the sequences upstream of the ORX 
intergenic sequence used in construct N-fORX-K, in the introns or 3’ flanking region of 
fugu ORX that were not investigated in this study. 
 
The fugu OE1 and OE2 elements are likely to contain regulatory motifs crucial for LHA-
specific expression similar to their human orthologs (Moriguchi et al., 2002) since they 
have some functional features in common with the human OE1 and OE2 elements. 
Firstly, fugu OE1 and OE2 worked cooperatively both in the context of the fugu ORX 
locus (N-fORX-K) as well as independently of the ORX locus (fOE2OE1-lac) to direct 
specific expression to LHA neurons (Figures 23D and 23F). Secondly, fugu OE1 in 
concert with the basal promoter (fOE1-lac) was not sufficient to reproduce endogenous 
gene expression in the LHA. However no ectopic expression was observed, unlike what 
was observed in the deletion analysis of Moriguchi et al (2002). Thus the fugu ORX basal 
promoter containing OE1 was unable to specify any expression in the hypothalamus, and 
required OE2 as an enhancer to interact with the promoter to specify LHA-specific 
expression. Deletion analysis of the fugu OE1 should be able to shed more light on the 
function of the regulatory motifs conserved between fugu and mammalian OE1, as well 
as between fugu and zebrafish (Faraco et al., 2006) and will be the subject for follow up 
work of the present study. In any case, my experiments have shown that OE1 required for 
LHA-specific expression did not arise only in mammals as previously hypothesized by 
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Moriguchi et al. (2002). The presence of elements orthologous to OE1 and OE2 in fugu 
has clearly shown that these elements are indeed ancient and were present in the common 
ancestor of mammals and fishes. These elements are therefore likely to be conserved in 
all bony vertebrates.  
 
The zebrafish study by Faraco et al. (2006) concluded that ORX regulation in mammals 
was different from that in zebrafish. This study found that the 1 kb zebrafish ORX 
5’flanking region could direct expression to the LHA in transgenic zebrafish, with a 250 
bp segment within this region containing a 13 bp core critical for expression. However 
there was no striking homology between this 13 bp core element and the 57 bp core of 
mammalian OE1; the 3.2 kb human ORX regulatory region could not specify any LHA 
expression in transgenic zebrafish; and deletion analysis of the zebrafish ORX regulatory 
region decreased efficiency but not specificity in directing LHA-specific expression in 
zebrafish (Faraco et al., 2006). My analysis of the fugu ORX regulatory region for 
conserved motifs has allowed me to locate the 57-bp core element in OE1, as well as two 
of the four regulatory motifs conserved between zebrafish and Tetraodon in the 250 bp 
segment crucial for LHA expression in zebrafish including the critical 13 bp core. It is 
striking that both the critical mammalian-like 57-bp OE1 core element and zebrafish 13-
bp core elements could be found in the fugu OE1 element albeit at low conservation. 
Since ectopic expression in the medial regions of the hypothalamus was not observed in 
the zebrafish study as well as in my transgenic analysis of the fugu ORX regulatory 
region, perhaps what has newly evolved in the mammalian system are enhancers that 
direct expression to those areas, and OE1 and OE2 in the mammalian ORX locus have 
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taken on the dual roles of enhancing LHA-specific expression as part of their ancestral 
function, as well as silencing medial hypothalamic expression as part of their novel 
function that is not present in teleost fishes. Since both enhancer and silencer functions 
are intricately linked, the mammalian OE1 and OE2 elements probably recruit a slightly 
different set of transcription factors compared to the fish OE1 and OE2 elements, and not 
all these factors might be present in the zebrafish hypothalamic system to sufficiently 
activate the mammalian OE1 and OE2 elements to give rise to transgene expression.  
 
In summary my work has demonstrated that in the absence of high sequence similarity, 
mammalian and fish species share the cis-regulatory information necessary for LHA-
specific expression of ORX gene.  Similar functional conservation of enhancers across 
distant phylogenetic groups in the absence of apparent sequence conservation has been 
recently reported for the RET receptor tyrosine kinase-encoding gene locus (Fisher et al., 
2006) and the propiomelanocortin (POMC) gene locus (Bumaschny et al., 2007).  Like 
the ORX locus, this conservation has been attributed to short functional regulatory motifs 
(4-20 bp) that are undetectable by the criterion (70% identity across >100 bp) used by 
Fisher et al. (2006) for identifying CNEs in distant vertebrate genomes. The enhancers 
identified using the CNE criterion seem to be found mainly in transcription factor genes 
involved in development as demonstrated for Six3 and Foxb1. Thus vertebrate genes 
seems to contain two distinct types of enhancers: one that is highly conserved over long 
stretches of DNA and associated with developmental regulators and another one 
associated with downstream genes in the gene-regulatory networks such as those 














          
Chapter 7 
 






The identification of evolutionarily constrained sequences is frequently used as part of a 
battery of approaches to identify and characterize functional sequences like cis-regulatory 
elements in the human genome. This is because functional sequences are likely to be 
under selective constraint and therefore tend to evolve slowly compared to the 
nonfunctional sequences flanking them. The objective of comparative genomics is to 
identify such constrained sequences by comparing genomes that are phylogenetically 
related. The longer the phylogenetic distance, the higher are the chances that the neutrally 
evolving regions would have diverged completely leaving behind footprints of highly 
conserved sequences representing functional elements. For identifying regulatory 
elements in the human genome, comparison with fishes is particularly attractive because 
fishes diverged about 420 million years ago from the mammalian lineage and thus 
represent the most distantly related bony vertebrates. With this in mind, I used a multiple 
alignment algorithm MLAGAN to compare 50 human forebrain-genes with their 
orthologs in mouse and fugu. My analysis identified 206 conserved noncoding elements 
(CNEs) that are longer than 50 bp and exhibit more than 60% identity. These CNEs are 
associated with 29 of the forebrain-genes analyzed. From these 206 CNEs, I validated 13 
CNEs associated with two developmental genes (Six3 and Foxb1) and found that all of 
them functioned as cis-regulatory elements, either as enhancers or silencers, directing 
spatial and temporal-specific expression of the genes associated with them. The 100% 
success rate of the functional assay of the 13 CNEs suggests that the remaining CNEs are 
also most likely to be cis-regulatory elements. This work has therefore demonstrated that 
comparisons between distant vertebrates like mammals and fish is a reliable approach for 
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identifying functional cis-regulatory elements in the human genome. My analysis did not 
identify CNEs in 21 of the 50 genes. However, functional analysis of the regulatory 
regions of one such gene (ORX) showed that although the regulatory elements in this 
gene locus are not highly conserved to qualify for being identified as a CNE, the 
regulatory elements are indeed conserved between mammals and fish at levels lower than 
the criteria used for defining CNEs. This indicates that lack of CNE should not be 
construed as an indication of nonfunctional sequences or that the mammalian and fish 
genes are regulated using different mechanisms. Indeed, in-depth functional annotation of 
1% of the human genome by the ENCODE project has revealed that while a large 
number of experimentally determined functional noncoding elements are under 
evolutionary constraint, many are unconstrained across mammals (Birney et al., 2007; 
Margulies et al., 2007).  
 
7.2 High-success rate in identifying functional cis-regulatory elements 
In my study all the 13 CNEs assayed in transgenic mice were found to function as cis-
regulatory elements. In typical CNE assays in transgenic mice, CNEs are cloned 
upstream of a β-galactosidase reporter linked to a minimal promoter from the mouse 
hsp68 gene and the function is assayed at one (E11.5) or two developmental stages. The 
success rate in such assays has been found to be about 29% for human-fugu conserved 
elements and 61% for human-fugu ultraconserved elements that acted as tissue-specific 
enhancers at E11.5 (Pennacchio et al., 2006). The high success rate in my assay can be 
attributed to the following: instead of the basal promoter from hsp68 gene, I used the 
basal promoter from the same gene, which should give high-specificity for interaction 
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between the enhancer and the basal promoter. The basal promoter has been shown to play 
an important and specific role in mediating the functions of enhancers (Smale, 2001). 
Therefore, the expression pattern of an enhancer driven by a heterologous basal promoter 
may not always reflect the physiological level or the actual expression pattern of the 
enhancers in vivo. My work has also clearly demonstrated that the basal promoters (about 
400-800 bp around the transcription start site) for Six3 and Foxb1 contain cis-regulatory 
elements directing tissue-specific expression. The CNEs dispersed in the intergenic 
regions interact with the basal promoter to drive tissue- and developmental-stage specific 
expression of the target gene. The high success rate in my assay might be due to the 
homologous basal promoters used in my study. One downside of this approach is that the 
expression levels of the reporter gene in my assays were generally lower than that 
observed with hsp68 promoter and as a result I had to use the more sensitive technique of 
in situ hybridization to detect the mRNA of the lacZ reporter gene, instead of β-
galactosidase staining used in studies with hsp68 promoter to detect expression of the 
reporter gene. The two homologous promoters used here seem to drive ß-galactosidase 
expression at lower efficiency during embryonic development than the hsp68 promoter. 
They are too weak a promoter to produce significant observable ß-galactosidase 
expression but can nevertheless drive detectable levels of RNA expression in a tissue-
specific and a developmental stage-specific way as shown in this study. 
 
Another reason for the high success rate in my assays could be that I checked the 
expression level at several stages of development from E9.5 to E15.5. Since many of the 
CNEs showed regulatory function in a temporal-specific manner, this approach was 
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useful to identify their function at different stages of development. A third reason for the 
high success rate might be due to assay of functions of some CNEs in clusters instead of 
testing them individually. However the analysis of a cluster of CNEs on basal promoter 
activity may not always recapitulate their physiological roles in the context of the intact 
gene. A complementary approach of deleting individual elements from the gene locus 
through specific targeting of CNEs by homologous recombination would be useful 
follow-up work to ascertain the precise physiological contribution of each enhancer to the 
tissue and temporal-specific expression of the gene. 
 
7.3 Cooperativity and redundancy in cis-regulatory elements 
Analysis of multiple CNEs from the Six3 and Foxb1 loci presented an opportunity to 
understand the interactions between CNEs. For example, I found that the basal promoters 
of both genes contain cis-regulatory elements and contribute significantly to the spatio-
temporal expression of the genes. Another interesting finding is that the cis-regulatory 
elements exhibit a high degree of cooperativity in their function. For example, CNE5/6/7 
and CNE12 cooperate to inhibit lens expression directed by the basal promoter at E15.5 
to help maintain a physiologically appropriate level of Six3 expression in the eye and 
suppress ectopic expression. Another interesting aspect that emerged from my study is 
the high level of redundancy among the multiple enhancers associated with a gene. 
Several enhancers were found to enhance expression or suppress expression in the same 
tissue at a particular developmental stage. For example, I discovered at least five 
silencers (CNE1, CNE2/3/4, CNE5/6/7, CNE8/9 and CNE14) that suppressed optic 
vesicle expression directed by the mouse Six3 basal promoter during E10.5-E11.5. This 
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indicates that the regulatory codes have a built-in redundancy to ensure that the genes are 
tightly regulated to obtain the correct expression patterns. The redundancy in the 
regulatory code also allows mutations and selections to act on redundant enhancers to 
acquire novel expression patterns. Evolutionary changes to cis-regulatory elements have 
been shown to have a high potential for morphological innovations and adaptive 
evolution (Wray, 2007). The modular nature and redundancy of cis-regulatory elements 
make them attractive template for adaptive evolution. 
 
7.4 Conserved function of cis-regulatory elements in mammals and fish without 
apparent sequence conservation 
My study has shown that the functions of regulatory elements could be conserved in 
distant vertebrates even though the sequences do not exhibit apparent conservation. I 
failed to identify any CNEs in the orexin (ORX) gene locus but functional analysis of the 
regulatory region of the fugu ORX showed that the function of the enhancer is highly 
conserved between fish and mammals. This means that functional information is 
conserved in these vertebrate sequences at levels below the metric used for identifying 
CNEs. Indeed a recent study comprehensively analyzed both conserved and 
nonconserved regions around the zebrafish paired-like homeobox gene phox2b for 
enhancer activity and found that many regulatory sequences (42-51%) are not detectable 
using standard methods for detecting evolutionary constraint (McGaughey et al., 2008). 
In addition, nonaligned sequences in the phox2b locus were shown to contain conserved 
transcription factor binding sites that would discriminate them from nonfunctional 
sequences, but these are distributed at a low density that makes them hard to detect by 
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alignment alone (McGaughey et al., 2008). It is likely that orthologous cis-regulatory 
elements control the expression of these genes but these elements have evolved beyond 
recognition through small changes in transcription factor binding sites, rearrangement of 
these binding sites or multiple coevolved changes that give rise to compensatory 
mutations along the enhancer as a result of a stabilizing selection process (Fisher et al., 
2006; Ludwig et al., 2000). Such weak constraint on functional sequence could be 
attributed to sequence degeneracy of binding sites or redundancy of individual functional 
elements or the need for secondary structure that is indirectly related to primary sequence 
(Cooper and Brown, 2008). The cis-regulatory elements of ORX gene locus belongs to 
one of these categories of enhancers. 
 
Enhancers have been classified into two models: the first is called the “enhanceosome 
model”, which describes enhancers as highly structured with a precise arrangement of 
transcription factor binding sites. The enhanceosome features a high degree of 
cooperativity between enhancer-bound proteins, such that alterations in individual 
binding sites can have drastic effects on enhancer output (Arnosti and Kulkarni, 2005). 
The high degree of conservation seen in the cis-regulatory elements of genes that encode 
transcription factors and involved in development like Six3 and Foxb1 indicate that they 
follow the enhanceosome model. The second model is the “billboard model” which 
describes enhancers as unstructured and representing loose assemblies of transcription 
factor binding sites that can vary in orientation and spacing. A billboard enhancer 
displays potential transcriptional information that is interpreted and deciphered by 
interaction with the basal transcriptional machinery, and exact positioning of bound 
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transcription factors is less critical than with an enhanceosome (Arnosti and Kulkarni, 
2005). Billboard enhancers are more evolutionarily pliable than enhanceosomes and can 
include extreme sequence and binding site divergence between functionally equivalent 
enhancers (Hare et al., 2008). This type of enhancers are likely to be present in the ORX 
regulatory regions characterized in this study, as well as in many other gene loci in which 
I could not detect any CNEs.   
 
In summary, no single metric of conservation can satisfactorily identify all the cis-
regulatory elements in the human genome. Although sequence conservation is a useful 
sign for identifying functional cis-regulatory elements, lack of conservation does not 
imply such noncoding sequences do not have a function. Functional cis-regulatory 
sequences in such regions can be more efficiently identified by comparing closely and 
distantly related vertebrates and by looking for conserved transcription factor-binding 
sites. Thus, a combination of several strategies is required for the identification of all the 
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Annex I: List of 50 genes expressed in the forebrain. The gene IDs of the human and 
fugu orthologs from Ensembl are indicated. 
 
 




1 Empty spiracles 
homeobox 1 
EMX1 ENSG00000135638 SINFRUG00000136589 
2 Aristaless related 
homeobox 
ARX ENSG00000004848 SINFRUG00000150852 
3 Ventral anterior 
homeobox 1  
VAX1 ENSG00000148704 SINFRUG00000120620 
4 Orthodenticle 
homeobox 1 
OTX1 ENSG00000115507 SINFRUG00000156103 
5 Retina and anterior 
neural fold homeobox 
RAX ENSG00000134438 SINFRUG00000147714 
SINFRUG00000136200 
6 Orthopedia homeobox OTP ENSG00000171540 SINFRUG00000129005 
7 GS homeobox 1 GSH1 ENSG00000169840 SINFRUG00000149945 
8 GS homeobox 2 GSH2 ENSG00000180613 SINFRUG00000126231 
9 Paired-like 
homeodomain 2 
PITX2 ENSG0000016409 SINFRUG00000155006 
10 Sine oculis-related 
homeobox homolog 3 
SIX3 ENSG00000138083 SINFRUG00000147597 
11 Sine oculis-related 
homeobox homolog 6 
SIX6 ENSG00000184302 SINFRUG00000149651 
12 Cartilage paired-class 
homeoprotein 1 
CART1 ENSG00000180318 SINFRUG00000145309 
13 LIM homeobox 2 LHX2 ENSG00000106689 SINFRUG00000135058 
14 LIM homeobox 5 LHX5 ENSG00000089116 SINFRUG00000159859 
15 LIM homeobox 6 LHX6 ENSG00000106852 SINFRUG00000147876 
SINFRUG00000127105 
16 LIM homeobox 8 LHX7/ 
LHX8 
ENSG00000162624 SINFRUG00000136556 













enhancer of split 1 
TLE1 ENSG00000196781 SINFRUG00000125941 
20 Single-minded 
homolog 1 
SIM1 ENSG00000112246 SINFRUG00000127347 


















25 Zinc finger protein of 
the cerebellum 2 
ZIC2 ENSG00000043355 SINFRUG00000151780 
26 GLI-Kruppel family 
member isoform 2 
GLI2 ENSG00000074047 SINFRUG00000153761 
SINFRUG00000149811 
27 GLI-Kruppel family 
member isoform 3 
GLI3 ENSG00000106571 SINFRUG00000153715 
28 Forkhead box G1 BF1/ 
FOXG1 
ENSG00000176165 SINFRUG00000125793 
29 Forkhead box B1 FOXB1/
FKH5 
ENSG00000171956 SINFRUG00000139631 
30 Forkhead box H1 FOXH1/ 
FAST1 
ENSG00000160973 SINFRUG00000146944 
31 Hypocretin (orexin) 
neuropeptide 
precursor 







33 Neuropeptide Y NPY ENSG00000122585 SINFRUG00000144489 
34 Agouti related protein AGRP ENSG00000159723 SINFRUG00000164565 
35 Thyrotropin-releasing 
hormone 
TRH ENSG00000170893 SINFRUG00000125121 
36 Somatostatin SST ENSG00000157005 SINFRUG00000143244 
37 Cocaine and 
amphetamine 
regulated transcript 











40 Proenkephalin PENK ENSG00000181195 SINFRUG00000165185 
41 Nerve growth factor 
(beta polypeptide) 




BDNF ENSG00000176697 SINFRUG00000142602 
43 Insulin-like growth 
factor 1 
IGF1 ENSG00000017427 SINFRUG00000140885 
44 Vasoactive intestinal 
peptide 
VIP ENSG00000146469 SINFRUG00000122509 
45 Cryptochrome 1 
(photolyase-like) 
CRY1 ENSG00000008405 SINFRUG00000140891 
46 Cryptochrome 2 
(photolyase-like) 
CRY2 ENSG00000121671 SINFRUG00000129038  
 161 
47 Ring finger protein 




48 Noggin NOG ENSG00000183691 SINFRUG00000142423 
49 Chordin CHRD ENSG00000090539 SINFRUG00000121889 
50 TGFB-induced factor 
homeobox 1 
TGIF ENSG00000177426 SINFRUG00000139204 
 
 
